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Cervical cancer is the second most common cancer in women worldwide. 
Epidemiologic studies have shown that the association of human papillomavirus 
(HPV) with cervical neoplasia is strong, independent of other risk factors, and 
consistent in several countries. The etiology of the cervical carcinoma have been 
linked to several oncogenic HPV types. HPV is the most diverse group of DNA 
viruses involved in human diseases. To date, 85 HPV types have been identified 
and more than 120 putative novel types have been partially characterized. The 
classification of the HPV types is based on the nucleotides sequences of E6 and E7 
as well as LI open reading frames (ORFs). The nucleotide sequences difference 
between 0 — 2% in the same type are classified as variants. Those differing by 2% 
to 10% are classified as subtypes. 
Abstract 丨丨 
The International Biological Study on Cervical Cancer (IBSCC) Study Group 
conducted an international study of HPV on invasive cervical cancer. Specimens 
from 32 hospitals in 22 countries except China were evaluated. Polymerase chain 
reaction (PGR) using HPV consensus primer pair MY09/11 was used to screen the 
1000 specimens collected. HPV was detected in 93% of the tumors with no 
significant variation in HPV positivity among countries. Some uncommon HPV 
types showed geographical variation. HPV 16 was the predominant type in most of 
the countries. It also predominated in squamous cell carcinomas and HPV 18 
predominated in adenocarcinomas and adenosquamous carcinomas. 
Cervical cancer is relatively common in the Mainland China. The study of 
HPV and cervical carcinoma started for more than 13 years. The rate of HPV 
infection among Shanghai women who had cervical cancer was 86.4% (32/37). In 
Jiangxi Province, the rate of HPV infection in cervical carcinoma was 100% 
(40/40). In recent years, some reports have indicated that HPV 52 and 58 are 
prevalent in cervical cancers among Chinese women. 
The aim of this study was to determine the prevalence of HPV in cervical 
carcinoma over China. It was the first extensive multiregional study in China. 
More than 800 cervical carcinoma tissues were collected in 5 regions of China; 
Sichuan, Beijing, Shanghai, Guangdong and Hong Kong. PCRs using HPV 
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consensus primer pairs MY09/11 and GP5+/6+ were used in the screening of HPV 
DNA in the samples. DNA sequencing, restriction fragment length polymorphism 
and HPV type specific PGR were used for HPV typing. Intratype variations of 
HPV were studied by using the DNA sequencing results. 
The overall HPV prevalence in cervical cancer in China was 83.9%, ranged 
from 79%-88% by regions. The infection rate of HPV 16 among total specimens 
was 66% whereas the infection rate of HPV 18, HPV 31, HPV 52 and HPV 58 was 
respectively 6%, 1.4%, 2.1%, and 3.1%. In fact, HPV 16 was the predominated 
type in all regions and in squamous cell carcinomas as well (68.7% of such 
specimens). Intratype variations of HPV types were not detected in this study. 
The results confirmed the role of etiologic factor of HPV in cervical cancer in 
China. The uncommon HPV type 52 and 58 were found to be highly prevalent in 
the southeast part of China. In fact, the information of this study is imperative for 




類乳頭狀瘤病毒(Human papillomavirus, HPV)感染在宮頸癌發生及發展過程中 
是重要的危險因子’尤其是HPV16型和18型。至今已鑑定的HPV型類別有 
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEWS 
1.1 Introduction 
Cervical cancer is the second most common cancer in women worldwide. 
Epidemiologic studies have shown that the association of human papillomavirus (HPV) 
with cervical neoplasia is strong, independent of other risk factor, and consistent in 
several countries. The etiology of the cervical carcinoma have been linked to several 
oncogenic HPV types (Bosch et al.’ 1995). Among all these types, HPV 16 is the most 
frequently found and a significant risk factor in its aetiology. 
To date, 85 HPV types have been identified and more than 120 putative novel types 
have been partially characterized (de Villiers EM, 1994). Among all these different 
HPV types, only about 40 types were found in anogenital cancer biopsy specimens. 
HPV types 16，18, 31，33, 39, 45, 52, 58 and 69 are considered to be high-risk types 
because they are most frequently found in high-grade cervical lesion and in an invasive 
cancer (Harald zur Hausen, 2000). HPV types 6, 11，42, 43，44 are rarely detected in 
cervical malignant lesions, so they are classified as low-risk types. 
The International Biological Study on Cervical Cancer (IBSCC) was organized to 
study the relationship between cervical carcinoma and HPV. They had collaborated 
with medical agents of 22 countries to collect the frozen cervical carcinoma biopsies for 
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the detection of HPV except China. The aim of this study was to determine the 
prevalence of HPV in cervical carcinoma in a worldwide perspective. Also, the 
oncogenic relationship between HPV and cervical carcinoma was studied. In fact, there 
were 93% of the tumors infected with HPV with no significant variation in HPV 
positivity among countries. HPV 16 was the predominant type in the cervical 
carcinoma and accounted for 50% of the specimens. HPV 18, HPV 31 and HPV 45 
were also found to have high a infection rate from 5% to 14%. There were some rare 
HPV types detected in the specimens in some countries. HPV 45 was apparent in 
western Africa and HPV 39 and HPV 59 were detected in Central and South America. 
These results demonstrated that some of the rare HPV types had geographic variation. 
(Bosch et al, 1995) 
Walboomers et al (1999) used the HPV negative specimens from Bosch's study 
(1995) to perform another experiments for HPV detection and the result was that the 
detection rate of HPV in cervical carcinoma increased to 99.7% whereas the detection 
rate of HPV in cervical carcinoma was only 93% in accordance with the study 
conducted by the ffiSCC. 
Cervical cancer is relatively common in the Mainland China (Pao et al., 1993). In 
China, the study of HPV and cervical carcinoma was started for more than 13 years. 
Most of the studies were conducted in a small scale and were regional-bounded. The 
rate of HPV infection among Shanghai women who were infected with cervical cancer 
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was 86.4% (32/37). In Jiangxi Province, the rate of HPV infection was 100% (40/40). 
All these studies proved that HPV plays an important role in the development of 
cervical cancer. 
In recent years, some reports indicated that HPV 52 and 58 were prevalent in 
cervical cancers among Chinese women. Another study from Hong Kong showed a 
significantly alter risk of cervical cancer associated with HPV 58 infection. (Chan et al. 
1999) A study in Shanghai showed that HPV 52 and HPV 58 played a more significant 
role (15 of 35 cases) in the etiology of cervical cancer. (Hunag et. al 1997) Again, 
according to a study in Jiangxi province, 40 cervical cancer specimens were screened 
for HPV types and the result showed that HPV 52 and HPV 58 contribute 20% of the 
total 40 samples. (Lin et al, 1998) 
Bosch et al (1995) used a HPV consensus primer pair MY09/11 (MY) that aimed 
at a 450 base pair (bp) fragment within the HPV LI open reading frame (ORF) for the 
detection of HPV DNA in cervical carcinoma. With a view to classifying HPV types in 
detail, 26 different HPV type specific probes that hybridized on the MY09/11 PCR 
products were used. In Walboomers's study, another HPV consensus primer pair 
GP5+/6+ (GP+) that targets the LI region was also used in screening the HPV negative 
specimens. The amplified region of GP5+/6+ primer pair was inside the region of 
MY09/11 primer pair, so a GP+ primer set was actually a nested primer of MY primer 
set. HPV type specific primers (TS primers) were used to detect the HPV types. These 
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type specific primers were designed to amplify the oncogenic E7 gene of HPV DNA. In 
Bosch's study, the infection rate of HPV was 93% but in Walboomers's was 99%. The 
difference between these two results (6%), indeed, may be either due to the absence of 
HPV DNA in the specimens or a false-negative HPV result. Integration of HPV DNA 
in cervical carcinoma may lead to a disruption in PCR primer sequences or a loss of the 
HPV LI ORE The E6 and E7 genes are almost invariable retained, as their expression 
is necessary for the conversion to and maintenance of a malignant state. (Schearz et al, 
1985; Durst et al” 1985; Choo et al, 1987; Wagatsuma et al.，1990; zur Hansen, 1994). 
These improvements of the detection methods may help to detect the actual HPV DNA 
in cervical carcinoma. 
The aim of this study was to determine the prevalence of HPV in cervical 
carcinoma over China. This was the first extensive multiregional study in China. It 
included 5 regions of China: Sichuan (central part of China), Beijing (northern part of 
China), Shanghai (eastern part of China), Guangdong (southeastern part of China) and 
Hong Kong (developed city in China). To verify the presence of DNA in the specimens 
used for PCR, a primer aiming at a 303bp fragments within human P-actin gene was 
used as an internal control of extracted DNA. All the specimens collected were 
mounted in a slide stained with H&E, graded, and were classified according to FIGO 
staging system. 
The PCR products of MY primer set were then used as templates of DNA 
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sequencing or restriction fragment length polymorphism (RFLP) to determine the HPV 
types. HPV type specific primers targeting E6 and E7 regions of HPV DNA were used 
as another method to determine the HPV types. When all the above methods were 
performed with the negative results, GP+ primer set was used as the last experiment to 
detect the HPV DNA. Intratype variation of the HPV in cervical carcinoma was also 
determined. This could provide information to see whether the wild types of HPV or its 
variants infect the cervix. 
The results of this study are essential to the development of vaccination strategies 
to cure cervical cancer. Since of the uncommon HPV type 52 and 58 were found to be 
comparatively prevalent among the Chinese population, the information gained in this 
study could help the vaccine developer to have a better understanding of HPV types 
and its variants in cervical carcinoma. 
In the following sections, the background information on the cervical carcinoma, 
HPV and its detection methods will be introduced. 
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1.2 Carcinoma of the cervix 
The majority of cervical carcinomas develop from an abnormal transformation 
zone. They are on the ectocervix in the young women and in the endocervical canal in 
the older woman. The position of the transformation zone determining the position of 
the tumor. The carcinomas may be exophytic and endophytic. Exophytic can be found 
in ectocervix and endophytic is in the canal. This causes an expanding tissues and 
producing the typical barrel-shaped cervix. 
Cervical carcinoma can spread locally into cervical stroma, the paracervical and 
parametrial tissue, the uterus and the vagina. At the later stage of carcinoma, the 
bladder and rectum can also be affected. 
The definitions of squamous carcinoma, adenosquamous carcinoma and 
adenocarcinoma will be introduced in the following sections. 
1.2.1 Squamous carcinoma 
Squamous carcinomas constitute more than 70 to 78 percent of cervical 
malignancies. (Buckley and Fox 1992). They may be well differentiated (large cell 
tumors showing well-marked keratinization), moderately differentiated (large cell 
tumors with focal keratinization), or poorly differentiated (large and small cell tumors 
with minimal evidence of keratinization). The majority of these neoplasms are 
moderately or poorly differentiated, only about 10 percent being well differentiated. 
Integrated and episomal HPV types 16 and 18 have been detected in squamous 
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carcinoma of the cervix. 
The well-differentiated carcinomas grow in bands or discrete islands whilst 
less-well-differentiated neoplasms grow in an infiltrative pattern or form solid sheets. 
The well-differentiated carcinomas are characterized by intercellular bridges and 
well-formed epithelial peals. 
Moderately differentiated squamous carcinoma shows a greater degree of cellular 
pleomorphism, higher nucleo-cytoplasmic ratios and more frequent mitoses. Epithelial 
pearls are rarely seen but individually keratinized, dyskeratotic cells, recognizable by 
their densely eosinophilic cytoplasm, occur singly or in small groups. 
Poorly differentiated squamous carcinomas are often diagnosed because their 
growth pattern or constituent cells are similar to those of a squamous neoplasm. 
1.2.2 Adenosquamous carcinoma 
Endocervical-type adenocarcinoma constitutes the largest group of cervical 
adenocarcinomas. A large number of reports indicate that, overally, adenocarcinomas 
have no difference in prognosis from squamous tumor. These tumors show a greater 
tendency to metastasize widely, even when the lesion in the cervix is small, and are 
disproportionately common in women under the age of 40 years (Buckley et al, 1988). 
Chapter 1 ： Introduction and Literature Reviews P. 15 
1.2.3 Adenocarcinoma 
Adenocarcinomas of the cervix appear to be increasing in incidence relative to 
squamous carcinomas of the cervix. Adenocarcinomas now constitute from 10% to 
25% of reported cases of cervical carcinoma. This may be due to an absolute increase 
of the adenocarcinomas or the stability of the adenocarcinomas. The age of 
adenocarcinoma patients are younger than that of the squamous cell tumors. Even 
within the adenocarcinomas group, the age is also decreasing. 
It is difficult to distinguish adenocarcinoma grossly from squamous carcinoma, 
having similar morphology and site of origin in the cervix. HPV types 16 and 18 have 
been identified in different types of adenocarcinomas of the cervix by means of PCR or 
other hybridization techniques. HPV type 18 is the most common type in 
adenocarcinomas. 
The prognosis for women with adenocarcinoma of the cervix is significantly worse 
than those with squamous carcinoma. The majority is composed of tissues resembling 
that of the normal endocervix and may be very well differentiated, so called minimal 
deviation carcinoma, or more typical endocevical carcinoma. They develop most 
commonly from the columnar epithelium of an ectopy, or more correctly from an 
adenocarcinoma in situ. Adenocarcinomas also exhibit neuroendocrine differentiation 
and there may，therefore, be systemic manifestations of their presence. HPV infection 
has been determined even in tumors of these types. 
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1.3 Molecular biology of Human papillomavirus 
In the age of molecular biology, the technology of cloning and describing the 
genetics of and organism has been well developed. According to the following studies, 
the whole organization of the human papillomaviruses has actually been observed. 
1.3.1 Genome structure and organization of HPV 
Papillomaviruses are small, non-enveloped DNA viruses with a circular, double 
stranded DNA genome of approximately 7200-8000 base pairs (Figure 1.1). All 
putative protein-coding sequences, called open reading frames (ORF), are restricted to 
one strand (Pfister et al., 1994; Gross and Krough, 1997) and each ORF segment of 
DNA is large enough to encode for a protein. 
The early (E) and late (L) sequences are classified according to the sequence of 
expression in the viral life cycle. E genes encode for viral replication and cellular 
transformation and are detectable in the proliferate areas of HPV-induced lesions. The 
late (L) genes, LI and L2 encode for the structural proteins and their expression is 
restricted to the differentiating part of the epithelium where viral DNA replication also 
occurs (Fuchs et al., 1994; Turek, 1994; Gross and Krogh, 1997). The promoter and the 
enhancer DNA sequences are located at the non-coding region (NCR) or long control 
region (LCR) or upstream regulatory region (URR) which in between E6 and LI genes. 
Enhancer and promoter DNA sequences are critical to viral replication. 
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Fig 1.1 Organisation of HPV 16 genome (adapted from Syrjanen, K. and Syrjanen, 
S. 2000) 
Chapter 1 ： Introduction and Literature Rev iews P. ] 1 
1.3.2 Expression of papillomavirus genes 
In the following sections, different HPV genes, El, E2, E4，E5, E6, E7, LI and L2 
will be introduced. 
HPV E l protein 
The El ORF represents the most conserved structure among different PV types. 
El codes for a polycistronic RNA and the El protein contains a highly conserved 
C-terminal region, with homology to SV 40 large T antigen such as ATP binding, 
ATPase and helicase domains as well as a divergent N-terminal domain (Clertant et al., 
1984; Seo et al., 1993; Yang et al., 1993). 
El is essential for viral replication (Ustav et al., 1991 a，b) and it also has an 
important role in retaining the episomal state of the viral molecule, i.e. it remains 
separate from the host cell chromosome (Sarver et al” 1984, Lusky et al” 1985). 
Mutational studies have recently shown that a mutation in the El ORF resulted in 
integration of HPV 31 (Frattini et al., 1996). 
El has a binding site in the origin of replication {ori) located in the proximal end 
of the LCR (Holt et al., 1994). El had been shown to interact with cellular DNA 
polymerase (Park et al” 1994; Bonne-Andrea et al” 1995) 
E 2 Protein 
E2 protein is a DNA-binding protein that regulates viral transcription and 
replication (Ham et al” 1991; McBride et al., 1991). It also acts as a potent 
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transcriptional activator and greatly increases viral DNA replication by co-localizing 
with El to the origin of replication. The full-length E2 protein (E2-TA) can function as 
a trans-activator or a repressor, depending on the location of the E2 binding sites in a 
responsive promoter. 
E4 Protein 
The interaction between PVs and the cytoskeleton seem to be mediated by viral 
E4 proteins derived primarily from the E4 ORF , which represents a region of maximal 
divergence between different HPV types (Brown et al., 1988; Door bar et al,, 1991; 
Jorreborg et al., 1991). The most abundant viral messages is formed by a single splice 
between the beginning of the El ORF contains the first five amino acids of the El ORF 
fused to the last 85 amino acids of the E4 ORF (Nasseri et al., 1987). Although E4 
proteins are expressed in large quantities in benign squamous cell papillomas, their role 
in the vims life cycle has remained exclusive. 
No mutation of HPV 16 E4 sequence results in a mutant protein, which fails to 
co-localize to the CK intermediate filaments. The C-terminal domain also is not an 
essential for association with the cytoskeleton, and deletion of the C-terminal 
sequences (residues 84-92) corresponding to the part of a domain conserved between 
mucosal E4 proteins, affects the ability of the mutant protein to induce cytoskeletal 
collapse, despite co-localization with the keratin intermediate filaments (Roberts et al., 
1994). These implicate that the E4 proteins include functional domains at the 
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N-terminus and the C-terminus, with the intervening sequences possible acting as a 
flexible hinge (Roberts et al., 1997) 
E5 Protein 
E5 is capable of causing efficient fibroblast transformation in the absence of other 
viral oncogenes. (Schiller et al., 1989; Horwitz et al., 1991; Auvinen et al,, 1997) It is a 
hydrophobic, 44 amino acid protein with two distinct structural features: (1) a 
hydrophobic 30 amino acid N-terminal region which functions as a transmembrane 
domain; and (2) a hydrophilic 14 amino acid C-terminal region which contains two 
cysteine residues essential for homodimer formateion (Burkhardt et al,, 1989 Tada et 
al., 1989; Sparkowski et al., 1996) 
It is less known about the E5 gene in HPV-induced lesions. The E5 ORF is 
located at the 3，end of the E region. In the nucleotide sequence of HPV 16, a putative 
E5 ORF was initially localized, but without a translation initiation codon of its own 
(Seedorf e/‘ al., 1985). Subsequently, however, this was found to be due to a sequencing 
error, and an additional T at nucleotide 3906 was found (Bubb et al., 1988). An 
initiation codon at nucleotide 3849 similar to the ORF of other PVs was recognized 
(Bubb et al., 1988; Halbert et al., 1988) 
Recently, some degree of homology between the HPV 18 E5 ORF and human or 
mouse genomic sequences have been found. Kahn et al (1992) described HPV 18 
E5-related transcribed mouse sequences, and Q300. Sequence alignments showed a 
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close similarity as well to Q300 (Kahn et al., 1992) and different viral and human 
growth factors, allowing it to be fitted into a putative phylogenetic chromosome 7, at 
7p 13-14，as determined by E5 sequences may constitute an HPV DNA integration 
target, which is often located near chromosomal breakpoints, oncogens, etc. (Geisen et 
al., 1995) 
E6 Protein 
In our study, most of the HPV type specific primers were designed within the E6 
and E7 regions. In the next 2 sections, the flinctions of E6 and E7 proteins will be 
introduced. 
The E6 protein is a major transforming protein of many types of PVs. E6 alone 
cannot immortalize human keratinocytes (Halbert et al., 1991; Sedman et al., 1991) but 
is capable of immortalizing mammary epithelial cells in culture (Band et al., 1990). 
HPV E6 is a basic protein that contains two C-terminal zinc-binding motifs. 
Mechanistically, the best-characterized E6 proteins are those of the high-risk gential 
HPVs (e.g. HPV 16 and HPV 18 E6). The schematic structure of HPV 16 E6 protein is 
given in Figure 1.2 E6 can form complexes in vitro with the tumor suppressor gene 
product p53 (Wemess et al., 1990), sharing similarities in respect with adenovirus ElB 
protein and the SV40 large T antigen. 
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Figure 1.2 Structure of HPV 16 E6 protein (adapted from Syrjanen, K. and 
Syrjanen, S. 2000) 
In contrast to ElB and large T, which inactivate p53 through their binding, E6-p53 
complex formation requires an additional cellular protein, E6-AP (Huibregtse et al., 
1991)，leading to complete degradation of p53. E6 binds directly to E6-AP protein, 
which functions as a specific ubuqutin-protein ligase, E3 targeting the E6-E6-AP 
complex to p53 (Huibregtse et al., 1993; Scheffner et al., 1993). The degradation of 
p53 proceeds through the ubiquitin-dependent pathway, which involve the activation of 
ubiquitin-conjugating enzyme E2 by ubiqitin-activating enzyme El, and transfer of 
uniquitin (E3) to a lysine reside of the target protein. E6, E6-AP and p53 is an absolute 
requirement for degradation. E6 mutants are capable of binding with p53 but have lost 
their ability of mediate degradation. (Crook et al,, 1991, Pirn et al., 1994; Dalai et al., 
1996). E6 can form a complex with p53 in the absence of E6-AP, although this 
interaction is much weaker than with E6-AP. (Lechner et al., 1994). 
The liner binding site for E6 within the p53 is still unknown. Different regions of 
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p53 are shown to be involved, and the conformation of p53 is important to form this 
complex (Scheffiner et al” 1992; Marston et al., 1994; Mansur et al., 1995; Kubbutat et 
al., 1996). Pirn et al., (1997) recently reported that HPV 18 E6* protein will interact 
both with the full-length E6 proteins from HPV 16 and HPV 18，and also with E6-AP, 
and subsequently blocks the association of the full-length E6 protein with p53. They 
also showed that, as a result of this block, E6* can inhibit E6-mediated degradation of 
p53, both in vivo and in vitro. The biological consequences of this are: (1) an increased 
transcriptional activity on p53-responsive promoters; and (2) an inhibition of cell 
growth in cells transfected with E6* (Pirn et al., 1997). This may represent a means by 
which HPV can modulate the activity of the full-length E6 protein with respect to p53 
during viral infection. 
E7 Protein 
E7 is a small acidic nuclear phosphoprotein with a zinc-binding motif located in 
its C-terminal half that is important for its stability and dimerization. The N-terminal 
region contains two conserved regions, CRl and CR2, which have sequence similarity 
to El A protein of adenovirus and large T antigen of SV40. Both regions are important 
for transformation in vitro. Mutations in these regions destroy transforming activity. 
The LXCXE motif, located within CR2 (residues 22-26), includes the binding site for 
the tumor suppressor gene product, retinoblastoma protein pl05 RB and the related 
pl07 and 130 proteins. (Dyson et aL, 1989, 1992; Firzlaff al., 1989; Vousden, 1993; 
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Kubbutat et al.，1996). These phosphorylation sites are needed for efficient 
transformation but not for pRB binding. Binding of E7 to the hypophosphorylated form 
of RB releases the transcription factor E2F. E2F motif has been found in the promoters 
of several cellular genes involved in cell proliferation. The structure of HPV 16 E7 
protein is illustrated in Figure 1.3 
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Figure 1.3 Structure of HPV 16 E7 protein (adapted from Syrjanen, K. and 
Syrjanen, S. 2000) 
Although efficient keratinocyte immortalization requires cooperation between the 
E6 and E7 
genes, HPV E7 (but not E6) can immortalize human keratinocytes alone 
when expressed at high levels (Halbert et al., 1991; Sedman et al., 1991). E7 protein of 
the low risk HPV types also binds to pRB but with lower affinity, indicating its 
significance in transformation. However, it should be noted that E7 of the low-risk 
HPV 1 can bind to pRB with the same affinity as E7 of HPV 16, indicating that 
mechanisms other than pRB binding are of importance for E7-associated malignant 
transformation (Ciccolini et al., 1994) 
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These studies suggest that both E6 and E7 maybe important proteins for both cell 
transformation and regulating the cell's mitotic cycle, allowing continuous proliferation 
of host cells. Human cancers are characterized by failure of cell cycle checkpoints, 
resulting in genetic instability. Clearly, E6 and E7 oncoproteins from high-risk HPV 
types are able to disrupt the integrity of these checkpoints. 
LI Protein 
The 2 consensus primers used in our study were designed to amplify the LI 
(55kDa) region because it was conserved among different HPVs. It is a major capsid 
protein. Cryo-electron microscopic image reconstructions of HPV capsids show that LI 
proteins from pentameric capsomers with a similar structure to those of polyomavims 
VPl protein, including a central hole in each capsomer similar to that of polyomavims 
(Baker al, 1991). 
The mechanisms that control HPV L gene expression are still not fully elucidated. 
Studies on the interaction of HPV with the host cells and the control of HPV L gene 
expression are hampered by the lack of an in vitro cell culture system for efficient 
propagation of the vims. The onset of the L genes coding for LI and the production of 
the virus are strictly linked to the differentiation stage of the infected cells, and LI 
proteins are detected primarily in terminally differentiated cells in the upper layers of 
the epithelium, the intimate association between HPV late gene expression and 
epithelial cell differentiation is likely to be regulated by cz.y-acting sequences on the 
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viral gene of viral mRNAs and by trans-diCimg viral or cellular factors produced in 
infected cells. 
L2 Protein 
L2 protein's (50kDa) function is unclear evidence suggests that although it is not 
require for receptor binding, L2 is required for infectivity (Mose-Larsen et al., 1987; 
Zhou et al., 1993; Roden et al., 1994a) L2 quantity is approximately 1/10 that of LI 
(Doorbar et al., 1987). Recombinant LI protein self-assembles into particles 
resembling virus capsids，but assembly is enhanced by the presence of L2 protein, 
which may be required for the assembly of infectious virions as well as for 
DNA-binding (Hagensee et al., 1993; Zhou et al, 1991, 1993). 
While studying the capsidation of HPV DNA, Zhou et al. (1994) showed that L2 
protein, but not LI protein, could bind the HPV DNA. Only the N-terminal of L2 was 
required for DNA binding. 
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1.3.3 Taxonomy of HPV 
Papillomaviruses have been classified as a subfamily (Shah & Howley，1992) 
together with polyomaviruses in the family Papovaviridae. There have been several 
reviews of the classification of papillomaviruses, both by phenotypic aspects and 
sequence similarities (Chan et al., 1992; van Ranst et al., 1992; Bernard et al, 1994; 
Myers et al； 1994; de Villiers, 1994; Chan et al., 1995) The characterization of anew 
HPV type was based on the viral DNA sequence from ORFs E6，E7 and LI and 
currently only from LI. The nucleotides sequences of the E6, E7 and LI genes differ 
by more than 10% from those of any previously described HPV types (de Villiers, 1994) 
will be classified as a novel type of HPV. The difference of the DNA sequences of 
these 3 genes is less then 2% is classified as variants. The difference between 2% to 
10% is classified as subtypes. (Gissmann et al., 1983; Deau et al., 1993; Ho et al., 1993; 
Ong et al., 1993) 
The similarities of E6, E7 and LI genes were used to identify and grouping of 
related HPVs into 5 subgroups. In the 5 subgroups of papillomaviruses, three contain 
HPVs (supergroups A, B, E). (Chan et a;/., 1995) The largest supergroup, A, includes 44 
HPV types and untyped genomes (Chan et al., 1995), can be subdivide into eleven 
subgroups. One of these groups contains HPV 16，HPV 31，HPV 33 and HPV 35 and 
another contains HPV 18 and HPV 45, the HPV types most frequently reported in 
association with malignant genital lesions. (Figure 1.4) 
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Until now, 85 HPV types have been identified and fully sequenced; more than 120 
putative novel types have been partially characterized, (zur Hausen, 2000). All 
identified types infected epithelial cells either of the skin or of the anogenital and 
oropharyngeal mucosa. No evidence for HPV infections has yet been found in the 
gastric, ileojejunal, or colon mucosa. 
The taxonomic status and the origin of the cloned genome from HPV 1 to HPV 70 





Figure. 1.4 Relationship among 95 human and animal papillomaviruses, in the 
form of a phylogenetic tree (adapted from Chan et al” 1995) 
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HPV Taxonomic Origin of cloned genome" HPV Taxonomic Origin of cloned genome"' 
type status type status 
(supergroup)' (supergroup)' 
HPV-1 E Verruca plantaris HPV-38 B Malignant melanoma 
HPV .2 a Verruca vulgaris HPV-39 A PIN 
HPV-3 a Verruca plana HPV-40 A PIN 
HPV-4 B Verruca vulgaris HPV-4I E Disseminated warts 
HPV-5 B EV lesion HPV-42 A Vulvar papilloma 
HPV-6 A Condyloma acuminatum MPV43 A Vulvar hyperplasia 
HPV-7 a Butcher's wart HPV-44 A Vulvar condyloma 
HPV-8 B EV lesion HPV-45 A CIN 
WPV-9 B EV lesion HPV~46 (= HPV-20b) (not recognized as separate 
HPV-10 A Verruca plana type) 
HPV-11 A Laryngeal papilloma HPV-47 B EV lesion 
HPV-12 B EV lesion HPV-48 B Cutaneous squamous-cell 
HPV-13 A Focal epithelial hyperplasia carcinoma 
HPV-14 B EV lesion HPV-49 B Verruca plana 
HPV-15 B EV lesion HPV-50 B EV lesion 
HPV-16 A Cervical carcinoma HPV-51 A CIN 
HPV-17 B EV lesion HPV-52 A CIN 
HPV-18 A Cervical carcinoma HPV-53 A Normal cervical mucosa 
HPV-19 B EV lesion HPV-54 A Condyloma acuminatum 
HPV-20 B EV lesion HPV-55 A Bowenoid papulosis 
HPV-21 B EV lesion HPV-56 A CIN, cervical carcinoma 
HPV-22 B EV lesion HPV-57 A Inverted papilloma of the 
B EV lesion maxillary sinus 
HPV.24 B EV lesion HPV-58 A CIN 
HPV-25 B EV lesion HPV-59 A VIN 
HPV-26 A Verruca vulgaris HPV-60 B Epidermoid cyst 
HPV-27 A Verruca vulgaris HPV-61 A VaIN " 
HPV-28 A Verruca plana HPV-62 A VaIN 
HPV-29 A Verruca vulgaris HPV-63 E Myrmecia 
HPV-30 A Laryngeal carcinoma HPV-64 A VaIN 
HPV-31 a CIN HPV-65 B Pigmented wan 
HPV-32 A Focal epithelial hyperplasia HPV-66 A Cervical carcinoma 
HPV-33 A Cervical carcinoma HPV-67 A VaIN 
HPV-34 A Bowen's disease HPV-68 A Genital lesion 
HPV-35 a Cervical carcinoma HPV-69 A CIN 
HPV-36 B Aclinic keratosis HPV-70 A Vulvar papilloma 
HPV-37 B Kcratoacanihoma 
Figure 1.5 Taxonomic association and origin of HPV types 1 to 70 
(adapted from lARC monographs volume 64) 
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1.4 Diagnostic techniques in HPV detection 
There are no suitable serological tests available for diagnosis of HPV infections, 
and the virus cannot be isolated from clinical specimens by cell culture techniques. 
Rapid progress made in the field of recombinant DNA technology, with the availability 
of specific probe, has enabled the detection of HPV genomic sequences in different 
clinical HPV lesions. Cytology and histology are usually sufficient for the proper 
diagnosis of clinical HPV infections, whereas DNA tests are necessary for reliable 
detection of subclinical and latent HPV infections. HPV DNA detection, however, 
increase the accuracy of HPV diagnostics. 
1.4.1 Southern blot analysis 
The extracted DNA from tissue, smear or cell cultures are digested with restriction 
enzyme or undigested. It can be electrophoresis according to their size to give different 
DNA fragments. The DNA fragments migrate to the cathode at different speed 
according to their size. Appropriate DNA size standard are run simultaneously. The 
DNA can be visualized on the agarose gel that stained with ethidium bromide under 
ultraviolet light illumination. The DNA will blotted on a membrane. The image of the 
electrophosis will exactly transfer to the membrane. After transfer to the membrane, a 
HPV type specific probe can bind on the membrane if the HPV DNA is stack on it. 
Nowadays, the probe can be radioactive or non-radioactive. By varying the 
hybridization conditions, heterologous DNA fragments can also be detected. After 48 
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hours of hybridization, the membrane is washed and put into the cassette for 
autoradiography for several days to weeks. The hybridized labeled probe yields distinct 
bands, corresponding to the complementary sequences in the cellular DNA. (Figure 
1.6) 
Southern blot technique can be determining the physical status of HPV in the 
samples detected. By using this technique, it can distinguish between episomal and 
integrated viral DNA. The physical status of the HPV in the host might provide an 
important information for the study of the transition of pre-malignant lesions to 
cervical cancer. Episomal DNA is mainly detected in benign lesions while integrated 
HPV DNA is mainly detected in cervical cancer. Moreover, sometimes rearrangements 
in the genome can also be detected. 
Southern blot is considered to be the "golden standard" for HPV detection and 
typing. The sensitivity of this method is about Ipg HPV DNA in lOjig genomic DNA 
can be detected. This method is time consuming and labor intensive process. It requires 
large quantities of sample DNA. 
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Figure 1.6 Schematic representation of the process of Southern Blot 
1.4.2 Dot blot analysis 
The dot blot procedure is a more rapid method for DNA hybridization. Using this 
technique, the extracted total cellular DNA is not digested with restriction enzyme. The 
DNA is not electrophoretically separated and fixed onto the membrane. The amount of 
DNA used in this technique is fewer than southern blot. Only 300-500ng of DNA per 
membrane is required. The sensitivity of dot blot hybridization is approximately one 
copy per genome equivalent when 500ng of cellular DNA is applied to the filter. The 
other reason why dot blot is not as accurate as southern blot is the band size is not 
determined. The signals of the dot blot produced may due to non-specific hybridization. 
This can be avoided by using high-stringency condition of each probe. Also if high 
copy number of HPV present in the sample, other type of HPV probes can hybridize to 
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the membrane. In this case, false positive result produced and this sample should not be 
interpreted as true positive. In addition, it has been shown that all the samples, whether 
HPV positive and negative, will hybridize with the HPV-probe under low-stringency 
conditions, because all DNA is focused on a single spot. (Melki et al., 1988; Roman et 
al., 1989). High quality of DNA, especially its purity, is mandatory for the specificity 
of the hybridization result. 
Dot blot analysis had been used to develop commercial HPV detection kits, called 
ViraPap and ViraType. They are developed by Digene, Silver Spring, Maryland, USA 
and have been widely used in several large scale epidemiological studies. (Munoz et al, 
1988, 1992a, c; Kjaer et al, 1989, 1990). 
1.4.3 In Situ Hybridization 
The strength of the in situ hybridization (ISH) technique is the preservation of 
morphology of the specimen, which permits localization of HPV within tissue and the 
infected cell (Brigati et al. 1983). Histological sections are cut on specially treated 
slides (Rentrop et al., 1989) to avoid the detachment of the sections during the 
hybridization procedure. The probe can be permeable to the cell by the proteinase 
digestion so the nucleic acid can be access to the sample. Denaturation of the target 
DNA and the labeled probe is done simultaneously, using high temperature. The probe 
will hybridize on the slide and the excess probe will be washed away. The detection of 
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target-probe duplexes is done either by autoradiography (for ^^S- or ^H-labelled probes) 
or by enzymatic detection methods (i.e. colour precipitation of labeled hybrids as a 
result of catalysis by enzymes, such as alkaline phosphatase or horseradish peroxidase). 
It is very difficult to detect the sensitivity of this method because the viral copy of 
each sample is different. Base on the cultured cell line analysis, known copy number of 
HPV is used. The sensitivity of the ^^S-probes vary between 20 and 100 copies per cell 
(Ostrow et al, 1987a; Collins et al., 1988). The sensitivity of biotinylated DNA probes 
varies from as low as 800 copies per cell (Collins et al., 1988) to the levels comparable 
with or even higher than that of ^^S-labelled probes (Bums et al., 1987; Syrjanen et al., 
1988; Heiles et al., 1988; Mullink et al, 1989). This wide variation in the sensitivity of 
biotinylated probes is due to the different detection system, rather than biotin itself. 
Sense and anti-sense RNA probes are both use in radiolabelled or biotinylated. Sense 
probe is RNA that is identical to mRNA and this will detect the DNA. Anit-sense RNA 
probes hybridized to non-denatured tissue sections will detect mRNA. It has been 
shown that RNA probes are more sensitive and specific than the comparable DNA 
probes. 
The benefit of in situ hybridization is that localize of the infected cell can be 
achieved. Only the HPV infected cells can be labeled, so the pathologists can be easily 
distinguished. The other advantage is the rate of false positive signals will be less. 
Using two consecutive sections stain together can exclude the false positive signals. 
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For paraffin-embedded samples that is poorly suited for dot blot or southern blot, ISH 
can be give a reliable result in detecting HPV. 
1.4.4 Hybrid Capture System 
Diagene Diagnostics has been one of the most active companies working with the 
development of HPV tests of clinical routine. The first two diagnostic tests provided by 
Digene Diagnostics were ViraPap (for HPV screening) and ViraType (for HPV typing), 
which were widely adopted in HPV research and routine clinical diagnosis as well. 
After a few years of use, however, it was realized that both these tests shared several 
disadvantages, inherent to dot blot. 
The most updated FDA approved HPV test is hybrid capture test. This is based on 
the solution hybridization principal. Hybird capture is a simple, non-radioactive 
immunoassay that employs RNA probes to detect single-stranded target DNA (Lorincz, 
1992; Ferenczy, 1995a). Hybrids are captured onto the surface of a plastic tube by 
immobilized antibodies specific for RNA-DNA hybrids. Detection of the hybrids is 
done with an alkaline phosphatase-conjugated RNA-DNA antibody, followed by 
incubation in a chemiluminescent substrate. A luminometer records the results, 
yielding quantitative results within 4 hours (Sun et al., 1995; Ferenczy et al” 1996; 
Reid et al 1996). 
Hybrid capture test can detect up to 16 different HPV types in a single reaction. 
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Those 16 HPV types are commonly found in lower genital tract. The sensitivity of this 
method is comparable to the traditional southern blot technique. Evaluation of hybrid 
capture test with highly sensitive primer-specific (GP+ primers) PCR had been done. 
Compare the hybrid capture system and consensus primer PCR for high-risk HPVs and 
reported a 86% agreement in a series of unselected consecutive patients (Farthing et al., 
1994). In screening cohort analyses of 967 smears, Schneider et al, (1996) found that 
hybrid capture detected only 50% of the HSILs. 
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Figure 1.7 Schematic representation of the process of Hybird Capture System 
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1.4.5 Polymerase Chain Reaction 
PCR is an in vitro method for primer-directed enzymatic amplification of specific 
target DNA sequences over a million times in a few hours. (Saiki et al., 1985; Mullis et 
al, 1987; Morris et al, 1988) PCR amplification of DNA is achieved by using 
oligonucleotide primers, also known as amplimers. These are short, single-stranded 
DNA molecules which are complementary to the ends of a defined sequence of DNA 
template. The primers are extended on single-stranded denatured DNA (template) by a 
DNA polymerase, in the presence of deoxynucleoside triphosphates (dNTPs) under 
suitable reaction conditions. The results in the synthesis of new DNA stands are 
complementary to the template strands. These strands exits at this stage as double 
stranded DNA molecules. Strand synthesis can be repeated by heat denaturation of the 
double-stranded DNA, annealing of primers by cooling the mixture and primer 
extension by DNA polymerase at a temperature suitable for the enzyme reaction. Each 
new DNA stand synthesis comprises a cycle of amplification. Each new DNA stand 
synthesized becomes a template for any further cycle of amplification and so the 
amplified target DNA sequence is selectively amplified cycle after cycle. (Fig 1.8) The 
first extension products result from DNA synthesis on the original template and these 
do not have a distinct length as the DNA polymerase will continue to synthesize new 
DNA until either stops or is interrupted by the start of the next cycle. The second cycle 
extension products are also of indeterminate length; however, at the third cycle, 
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fragments of ‘target，sequence are synthesized which are of defined length 
corresponding to the positions of the primers on the original template. From the fourth 
cycle onwards the target sequence is amplified exponentially. 
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Figure 1.8 Schematic representation of the process of polymerase chain reaction 
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If enough amplified DNA is available, diagnosis can be read directly on the gel after 
electrophoresis and ethidium bromide staining. However, all gels have to be hybridized 
with specific oligonucleotide probes covering part of the amplified DNA to confirm the 
specificity of the PCR product. Hybridization will usually result in additional positive 
samples not visible in the gel, because it sensitizes the method further. In additional to 
hybridization, the specificity of PCR results can be confirmed by restriction enzyme 
digestion or direct sequencing of the PCR product. The sensitivity of PCR depends on 
several factor, including the concentrations of target DNA, polymerase enzyme, 
Mg-ions，primers etc. 
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1.5 Human papillomavirus in cervical carcinoma 
1.5.1 Prevalence 
From the epidemiological point of view, it is of critical importance to establish the 
prevalence of genital HPV infection at the population level, as a measure of the disease 
burden in the general population (Bosch et al., 1995; lARC, 1995). This can be 
measured in different populations with a suspected different prevalence of HPV 
infections, including virgins and nuns, healthy women with normal PAP smear (a low 
prevalence group), those attending STD clinics (high prevalence), those suffering from 
immunosuppression (due to AIDS or transplantation), as well as women with a 
detected cervical cancer (Fisher et al., 1991; Griffiths, 1991; Chang et al, 1992; 
Lorincz et al, 1992; Meekin et al., 1992; Agorastos et al., 1995; Bosch et al., 1995, 
Persson et al., 1996). The detection rate of HPV is critically depends of the sensitivity 
of the detection techniques, and only the most sensitive PCR methods can provide 
useful information on the prevalence of HPV in heavy mucosa (lARC, 1995). 
As the development of PCR technique, there are many studies on the prevalence 
of HPV infection had been published. The studies used PCR amplification for the 
detection of HPV, the variation reported (0-47.9%) in the prevalence of HPV DNA in 
these PAP smear-negative women is remarkably high. One of the sources of 
inconsistency is the technique of PCR amplification. It is because PCR can detect even 
1 copy of HPV DNA. This will give the false positive result. However, some of the 
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studies showed the HPV DNA prevalence is age-dependent, with the highest 
prevalence figures found in younger women. (Purola et al., 1977; Syijanen, 1979a,b). 
Some of the studies showed that HPV DNA seems to be virtually absent in women 
with no reported sexual activity (Fairley et al., 1992; Rylander et al., 1994; Critchlow et 
al., 1995a) According to the data; there is no geographical variation in the prevalence 
and the type distribution of HPV infection. These data are collected in the PAP 
smear-negative women. However, lARC had done a research on worldwide prevalence 
of HPV infection. In this finding, there are significant geographic and ethnic 
differences in the distribution of certain HPV subtypes and HPV type variants. 
Prevalence of HPV in cervical cancer in China 
The study of HPV in cervical cancer has been started for 13 years and still ongoing 
now. Most of the studies were in small scale and regional bounded. There were several 
studies on HPV in cervical cancer conducted in Sichuan, for instance, Tang et <2/(1991) 
conducted a study on the prevalence of HPV in the general population of high 
incidence regions and low incidence regions of cervical carcinoma of Sichuan. 
Meanwhile, the risk factors were also studied in his study. In accordance with Tang's 
study，HPV infection rate in high incidence area was 18% and that in low incidence 
area was 3.4% in general population. This showed that the HPV infection rate in high 
cervical carcinoma incidence area was 5 times higher than that in the low incidence 
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area. It also suggested that the number of sexual partners and the nutrients absorption 
could be the risk factors of HPV infection in Sichuan. 
Another study was mainly on the relationship between HPV and cervical 
carcinoma not in the general population. The result of this study showed that only 35% 
(35/101) of cervical cancer cases were HPV-infected. The positive specimens were 
infected with HPV 16 and none from HPV 33. A study performed by Stephen Al et al 
(2000) showed that the infection rate of HPV in Sichuan was 88% (28/34) and this rate 
was much higher than that in Peng's study in 1991. The infection rate of HPV 16 and 
HPV 18 was 61% and 9% respectively. HPV types 33, 45，58 and 59 were also 
identified in the samples. 
Apart from Sichuan, the situation of HPV and cervical cancer also studied at 
Shanghai. At 2 hospitals of Shanghai, the HPV 16 infection rates were 27.8% and 
15.8% respectively whereas in Jiangxi the infection rate was 70.9%. In the fresh tissue 
specimens from Shanghai and Jiangxi, HPV 52 were detected but none could be found 
in the paraffin-embedded tissue but in Shanghai frozen tissue, the percentage of 
infection was 16.7% and there was only 2.5% in Jiangxi. When comparing the 
prevalence of HPV 58 in Shanghai and Jiangxi, two different regions had no significant 
difference, varying from 15.8% to 22.2%. 
In Beijing, Zhang et al had conducted a research using 3H-dCTP-labelled 
HPV-16 probe. The results showed that the HPV-16 DNA positive rate was 74.4% 
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(29/39). Another research in Shanxi Province using dot blot hybridization to detect the 
HPV DNA showed 40% of the invasive cervical carcinomas were infected with HPV 
16. Using LI consensus primer for detection of HPV in cervical cancer tissues was 
another method used in Shanxi Province (Zhao et a l , 1994). The HPV infection rate of 
total 40 samples was 85%. For adenocarcinoma, HPV 18 were detected in 9 specimens 
(45%) and only 5 specimens were detected with the infection of HPV 16 (15%). HPV 
16 were detected in 80% of the squamous cell carcinoma samples where HPV 18 only 
counted for 5%. The results indicated that HPV type 16 was detected more often in 
squamous cell carcinoma than in adenocarcinomas while HPV type 18 was detected 
significantly more often in adenocarcinoma tissues. 
There were several studies conducted by the University of Hong Kong and the 
Chinese University of Hong Kong in HPV and cervical cancer. In 1994，Ngan et al. 
used HPV 16 and HPV 18 E6 type specific primers to screen the 64 cervical 
carcinomas and it was discovered that 90% of the samples show positive in the HPV 
DNA screening and 67.2% had HPV 16 infection. Chan et al conducted a research on 
HPV and abnormal PAP smear in 1998. Among 18 cervical carcinoma cases, 14 were 
infected by HPV. There were 8 specimens which were found to be infected by HPV 16 
(44.40/0), 6 by HPV 58 (33.3%), and 1 by HPV 18 and HPV 31 respectively. High 
prevalence of HPV 58 in cervical carcinoma and also in other grades of cervical lesions 
was detected. These observations might indicate that the worldwide uncommon 
Chapter 1 ： Introduction and Literature Reviews P. 15 
genotype, HPV 58 played an important role in the development of cervical cancer in 
Chinese. 
In Taiwan, the combined presence of HPV 52 and HPV 58 was detected separately 
or together in over 25% of HPV positive subjects compared with the fact that only 5% 
of HPV positive subjects were detected in a large international study conducted by 
IBSCC in 1995 as well as by Liaw et al (1995). 
From the studies conducted, HPV 16 is the dominant HPV type in cervical 
carcinoma and HPV 52 and HPV 58 have a significant high infection rate in China than 
that of other countries. 
1.5.2 Transmission 
Most of the genital warts are transmitted sexually. This kind of transmission is 
well accepted and regard as the most important route of infection in sexually active 
adults (Oriel, 1971b，1981，1988). Data confirming this concept are derived from 
different epidemiology approaches. In the study of virgin and nuns, there are no HPV 
found. (Fairley et al., 1992; Gutman et al., 1994; Rylander et al., 1994, Critchlow et al., 
1995a). With increasing sexual experience, the risk of infecting with HPV seems to be 
increased. Critchlow et al. (1995a) suggested that this risk increase in parallel with the 
number of sexual partner. At present, evidence implicating the number of sexual 
partners as one of the most significant risk factors for genital infections is compelling 
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(IARC,1995). When studying the transmission of HPV, the virus reservoirs have to 
found. Most of the HPV found in the epithelium of the penis, urethra and prostate. 
(Hillman et al., 1993a, Kyo et al., 1994; Rotola et al., 1994; Baken et al, 1995) This is 
confirmed using highly sensitive PCR-based HPV detection techniques. The other 
transmission is maternal-infant transmission. Roman et al. (1989) suggested this 
assumption because he found HPV 6 and HPV 16 DNA in the normal foreskin of 
newborn by dot blot hybridization. 
In non-sexual transmission of HPV, autoinoculation, infection from moist 
dwellings, contaiminated instruments and underwear and vertical transmission from an 
infected mother to her newborn baby are some of the routes. The vertical transmission 
from an infected mother to her newborn baby is of particular clinical relevance. There 
is HPV 16 and 18 DNA sequences have been found in nasopharyngeal aspirates from 
neonates, laryngeal tissue from infants, and cytological samples from virgins. The 
conclusion seems inescapable that some but not all cervical HPV infection is acquired 
by means other than sexual intercourse. 
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1.5.3 Risk Factors 
Before the link of HPV and cervical cancer was established, compelling 
epidemiological evidence suggested that cervical cancer bears close similarities with 
STDs. One of the characters of STD is a multiple sexual partner. Some of the studies 
had shown that women with multiple sexual partners, promiscuous sexual partners, and 
early onset of sexual activity are high risk group having cervical cancer. (Munoz et al., 
1989; Bosch et al., 1994, 1995; Ponten et al., 1995; Schiffinan, 1995a, b; Morris et al., 
1996; Franco et al” 1997). In the late 70，s, strong evidence from the different approach 
indicated that HPV, certain oncogenic types of HPV, may play an important role in 
pathogenesis of cervical cancer. In addition to these infection agents, other factors have 
been suspected or shown to increase the risk for cervical cancer: low socioeconomic 
status，reproductive history, smoking habits, oral and barrier contraceptive use, dietary 
factors, immunosuppression, frequency of PAP smears, and characteristics of the male 
sexual partners. (Munoz et al., 1989; Bosch et al., 1994, 1995; Ponten et al., 1995; 
Schiffinan, 1995a,b; Morris et al., 1996; Franco et al., 1997). Many of these factors are 
the same as those predisposing women to genital HPV infections and CIN. All the 
above factor are closely related and it is difficult to assess their independent roles as 
risk factors. But most recent studies emphasizing the role of HPV as an independent 
risk factor (Morris et al., 1996; Franco et al., 1997) 
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Sexual Characteristics 
One of the sexual characteristics linked with an increased risk of cervical cancer 
was number of male sexual partners. (Bosch et al., 1989，1993，1994; Brinton, 1992). 
As the number of male sexual partners increased, the risk of cancer precursors and 
invasive cervical cancer increase parallel. So this is a strong risk factor of cervical 
cancer. (Herrero et al., 1990; Bosch et al., 1992; Koutsky et al., 1992; Munoz et al., 
1993a，b) Indeed the number of sexual partners was a significant risk factor for genital 
HPV, as demonstrated in the early case-control study of Syrjanen et al. (1984b). 
Another sexual risk factor is the first age of having sexual intercourse. (Herrero et 
al., 1990; Bosch et al.，1992; Koutsky et al., 1992; Munoz et al., 1993; Schiffinan et al., 
1993) There are several studies show that an early onset of sexual activity on the risk of 
cervical cancer after controlling for potential confounders, other studies have failed to 
show any such independent effect (Jones et al., 1990). 
Reproductive Factors 
There are some reproductive characteristics have been analyzed as risk factors for 
cervical cancer. (Chang, 1989; Hildesheim et al., 1990; Brinton, 1991; Guo et al., 1994; 
Key，1995) These include: age at menarche, age at menopause, parity, number of 
spontaneous or induced abortions, age at first pregnancy, age at first live birth, age at 
last birth, number of vaginal deliveries, and number of Caesarean sections. (Herrero et 
al., 1990; Bosch et al., 1992; Kjaer et al., 1992; Munoz et al., 1993; Becker et al., 1994) 
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Smoking Habits 
Cigarette smoking is classified as one of the most important risk factor of 
cervical cancer. These studies have been work over than 20 years. Until 1990， 
Winkelstein (1990) and several have provided evidence supporting an association 
between cigarette smoking and invasive cervical cancer or CIN. The smokers have 
shown at least two-fold increased risk of getting cervical cancer. After the adjustment 
of other factors such as sexual behavior, the risk a slight decreased but still significant 
high and independent. (Greenberg et al., 1985; Brock et al., 1989; Baling et al, 1992a, 
1996) The reason of cigarette smoking cause cancer is due to the biochemical element. 
In a cigarette, some of the carcinogens such as nicotine, cotinine and other mutagenic 
substances has been found in the cervical mucus of women actively or passively 
exposed to tobacco smoke. (Hellberg et al” 1988; Prokopczyk et al.，1997) These 
carcinogens may cause DNA damage due to direct carcinogenic effect, co-carcinogenic 
effect or local immunosuppressive effect. The DNA damages levels in cervical tissue 
cells and exfoliated cells of female smokers was significant higher then non-smokers. 
But now most of the recent studies have not supported smoking as an independent risk 
factor for cervical cancer. The detection rate of HPV DNA was identical in smokers 
and in women who had stopped smoking, suggesting that smoking does not increase 
risk of invasive cancer by prolonging the persistence of HPV DNA (Fairley et al., 
1995). 
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Oral Contraceptive 
When the oral contraceptive starts to use, many studies start to blame 
contraceptives as a risk factors for many diseases including CIN and cervical cancer. 
But during the research and interpretation of the epidemiological data, the scientists 
found many problems. Even the recent studies controlling the HPV status are equally 
conflicting with the previous. (Brinton et al.，1990b; Bosch et al., 19921 Koutsky et al., 
1992; Becker et al, 1994) We cannot conclude that oral contraceptive use is an 
independent risk of cervical cancer. 
Dietary Factors 
It is difficult to determine the relationship independently of certain nutrients and th 
human malignancies. Some studies suggest 60% of cancers in women and 40% of 
cancers in men could be ascribed to nutritional factors. The action of nutrients usually 
show protective again neoplasm rather that positive risk association. So there are some 
nutrients have protective effect against cancer, such as vitamin A, carotenoids, vitamin 
C and vitamin E and folic acid. (Schneider et al., 1989; Cuzick et al, 1990b; Ziegler et 
al.，1990; Amburgey et al, 1993; Liu et al., 1993; Potischman et al. 1996) 
Epidemiological studies on the association of vitamin A, carotenoids, vitamin C and 
folic acid with cervical cancer are hampered by difficulties in measuring nutrients 
levels (Potischman et al., 1996). Predictably this source of bias has led to conflicting 
results and difficulties in comparing findings. (Schneider et al., 1989; Cuzick et al., 
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1990b; Ziegler et al. 1990) The study of nutrients effect should be focusing on the 
interaction with other risk factors such as smoking and HPV. Also the role of different 
nutrients intake among distinct ethnic and racial groups should be examined in more 
details. 
Human Papillomavirus 
When studying the relationship between HPV and cervical cancer, the method is 
the identical to those described before for CIN. When first report on the morphological 
evidence of HPV involvement in an invasive cervical cancer (Syijanen, 1979a), many 
other studies of cervical cancer were detecting the presence of HPV DNA using 
different techniques. As the detection techniques and the sensitivity improved as time, 
the detection rate are keep on increasing. In the 70，s and 80,s，southern blot or other 
hybridization techniques were used as a gold standard in detecting HPV DNA in the 
cervical cancer tissue. When the PCR techniques developed, most of the research are 
relies on this. The HPV detection rates vary between than 50% to 100% (lARC, 1995). 
Comparing the research using PCR techniques rather then other hybridization 
techniques, the detection rate of PCR-based research is around 75% (57%-100%) 
which was higher than the average of hybridization techniques. From these results, it 
can conclude that the correlation between HPV and cervical cancer is strong. A large 
number of studies on extensive series of cervical carcinoma s almost unanimously 
confirm the detection of HPV DNA in the vast majority of these lesions. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Materials 
The chemicals and reagents listed below were used in this study. 
2.1.1 Chemicals and regents 
Chemicals Companies / Manufacturers 
1. [丫32卩]ATP (lOmCi/ml) (Amersham, Buckinghamshire, UK) 
2. 1 OX Taq DNA polymerase buffer (GibcoBRL, Grand Island, USA) 
3. 6% GENE-PAGE PLUS, EZ S Q U E E Z E ™ (Amersco, Ohio, USA) 
4. Absolute ethanol (analytical grade) (Sigma, St.Louis, USA) 
5. Agaroses 3:1 (High Resolution Blend) (Amersco, Ohio, USA) 
6. Boric acid (Ultra pure) (GibcoBRL, Grand Island, USA) 
7. Bovine serum albumn (Fraction V) (Sigma, St.Louis, USA) 
8. Bromophenol blue (Sigma, St.Louis, USA) 
9. Chloroform (Sigma, St.Louis, USA) 
10. dNTP (2'-deoxynucleoside 5'-triphosphate) (GibcoBRL, Grand Island, USA) 
11. Ethidium bromide (Sigma, St.Louis, USA) 
12. Ethylenediaminetetraacetic acid (EDTA) (Sigma, St.Louis, USA) 
13. Ficoll (Type 400) (Pharmacia, Buckinghamshire,UK) 
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14. Formamide (Amersco, Ohio, USA) 
15. Isopropylthio-P-D-galactoside (IPTG) (Promega, USA) 
16. Phenol/chloroform/isoamy alcohol (25:24:1) (GibcoBRL, Grand Island, USA) 
17. Polyvinylpyrrolidone (Sigma, St.Louis, USA) 
18. Proteinase K (Sigma, St.Louis, USA) 
19. Restriction enzyme Rsa I and Dde I (lOU/！i l)(Roche, GmbH, Germany) 
20. Salmon sperm DNA, denatured, fragmented (Sigma, St.Louis, USA) 
21. Sodium acetate (GibcoBRL, Grand Island, USA) 
22. Sodium chloride (Amersco, Ohio, USA) 
23. Sodium citrate (Amersco, Ohio, USA) 
24. Sodium dodecyle sulfate (SDS) (GibcoBRL, Grand Island, USA) 
25. T4 polynucleotide kinase with forward buffer(GibcoBRL, Grand Island, USA) 
26. Tag DNA polymerase (5U/ //1) (GibcoBRL, Grand Island, USA) 
27. 5-Brono-4-chloro-3-indoyl-P-D-galactoside (Promega, USA) 
(X-Gal) 
28. Xylene cyanol FF (Sigma, St.Louis, USA) 
29. Xylene (Sigma, St.Louis, USA) 
30. OX-174 RF DNA (GibcoBRL, Grand Island, USA) 
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Reagents 
LB Medium (Luria-Bertani Medium) per liter 
To 950ml of deionized water, add: 
Bacto-trypton lOg 
Bacto-yeast extract 5g 
NaCl lOg 
Adjust the pH to 7.0 with 5N NaOH (�0.2ml). Adjust the volume of the solution to 1 
liter with deionized water. Sterilize by autoclaving for 20 minutes at 15 Ib/sq in. on 
liquid cycle. 
SOC Medium 
To 950ml of deionized water, add: 
Bacto-trypton 20g 
Bacto-yeast extract 5g 
NaCl 0.5g 
IM glucose 20ml 
Adjust the pH to 7.0 with 5N NaOH (�0.2ml). Adjust the volume of the solution to 1 
liter with deionized water. Sterilize by autoclaving for 20 minutes at 15 Ib/sq in. on 
liquid cycle. 
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TE Buffer 
Tris CI (pH 7.4) lOmM 
EDTA (pH 8) ImM 
Sterilize by autoclaving for 20 minutes at 15 Ib/sq in. on liquid cycle. 
PNK Buffer 
Tris Base lOmM 
Ethylenediaminetetraacetic acid (EDTA) 1 OmM 
Loading dye 
Bromophenol blue 0.25% 
Xylene cyanol FF 0.25% 
Ficoll (Type 400) in water 
50XDenhardt，s reagent 
Ficoll (Type 400, Pharmacia) 5g 
Polyvinylpyrrolidone 5g 
Bovine serum albumn (Fraction V, Sigma) 5g 
Adjust the volume of the solution to 500ml with deionized water and sterilize by 
filtration through a 0.22-micron filter. 
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2.1.2 Specimens collection 
One hundred and ninety-five cervical cancer tissues were collected at Prince of 
Wales Hospital，Hong Kong Special Administrative Region, China from 1992 to 1998. 
They were snap frozen in liquid nitrogen and embedded in OCT compound, stored in 
-80�C before DNA extraction. Six hundred and sixty-eight paraffin-embedded cervical 
carcinoma tissues were collected from Shanghai (eastern of China), Sichuan (central of 
China)，Beijing (northern of China) and Guangdong (Southern of China) of China for 
this study. 
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2.2 Methods 
In this study, several HPV detection methods were used. Firstly, the DNA was 
extracted from the paraffin sections and fresh tissues. It would undergo MY09/11 PCR 
screening. The positive PCR products were used in DNA sequencing and RFLP for 
HPV typing. Those samples that negative with MY09/11 screening were screened using 
P-actin PCR. The negative specimens were excluded in this study. The second part of 
screening was used the HPV type specific primers. The samples that shown negative in 
DNA sequencing or RFLP and those positive with P-actin PCR were screened by using 
HPV type specific primers. Finally the GP5+/6+ consensus primers were used to screen 
the negative samples in the HPV type specific primers PCR screening. The summarized 
methodology was showed at section 2.2.1. 
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2.2.1 Summary of methodology 








DNA sequencing B-actin PGR 
Success Unsuccessful Positive Negative 
+ + \ + HPV typed RFLP \ False negative 
^ ^ ^ Type Specific PGR 
Success Unsuccessful I 
• + + 
Positive Negative 
HPV typed ^ • 
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^ I ^ True negative 
Success Unsuccessful • + 
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2.2.2 DNA extraction from fresh and paraffin embedded tissues 
A snap frozen cervical carcinoma tissue was grounded in a 15ml Falcon tube. The 
grounded tissue was then re-suspended in Proteinase K buffer (50mM Tris (pH8.0), 
ImM EDTA, 0.5% Tween 20). 1/10 volume of the Proteinase K was added to the tissue 
and incubated at 37°C water bath overnight. The tissue was then extracted with equal 
volume of phenol/CHCls/isoamy alcohol phenol twice and once with equal volume of 
chloroform. 
The supernatant was transferred to the eppendorf tubes, 3M NaOAc (pH5.2) and 
absolute ethanol was added to the samples and left at 4°C overnight (16 hours) to 
precipitate the DNA. Next day, the tubes were centrifuged at 13,000 rpm for 15 minutes; 
the pellet in each tube was washed with 70% ethanol. The DNA pellet then was dried in 
SpeedVac concentractor, dissolved DNA with TE buffer. The samples were finally 
stored at -20°C for future use. 
A single 10/zm formalin fixed, paraffin-embedded cervical carcinomas tissue 
section was put in the autoclaved 1.5ml eppendorf tube. It was deparaffinized by 
extraction twice with 1ml xylene for 20 minutes each at room temperature with 
constant shaking. Absolute ethanol (1ml) was then added to the tube for 5 minutes. The 
sample digested with proteinase K solution overnight followed by phenol-choloroform 
extraction twice and ethanol precipation as described above. The DNA was precipitated 
by adding 40|al 3M NaOAc ( pH 5.2 ) and 1 ml absolute ethanol, and left overnight at 
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-20°C.The DNA samples were lastly prepared for later use: recovering the DNA by 
spinning it at 13,000rpm for 20 minutes at room temperature, washing it with 70% 
ethanol, drying the DNA pellet in SpeedVac concentrator, dissolving in lOjiil TE buffer, 
and storing at -20°C until use. 
Microdissection of cancer cells was performed when the cancer cells were less 
than 50% from the whole tissue section. Three consecutive 5-micron sections from a 
formalin fixed paraffin embedded block were cut and placed onto slides. Another 
section stained with H&E was used as a guilded section. A sterilize new #11 blade and 
needles were used to collect the dissected areas. The collected cells were placed 
carefully into the 0.5 ml tube with the TE buffer and extracted as above. 
Cliapter 2: Materials and Methods K53 
The following 16 steps were adopted in DNA extraction from paraffin sections 
1. Extract lOjiM section with lOOOjil xylene incubate at Room Temp, for 20 minutes. 
2. Spin for 5 minutes at ISOOOrpm in microfuge 
3. Decant xylene 
4. Repeat steps 1-3 
5. Extract with lOOOfil ETOH, incubate at Room temp, for 5 inins. 
6. Spin for 5 minutes at ISOOOrpm in microfuge 
7. Decant ETOH 
8. Repeat steps 5-7 
9. Dry samples in Speed-Vac for 20 mins 
10. Resuspend in 3()()}il PNK buffer with 3|il prot.K. Incubate at 37�C for 8-18hrs 
11. Boil sample for 5 minutes at 95°C 
12. Extract IX with phenol/CHCL3/isoamy alcohol 
+ add 3()0|il of the mixture to the sample 
mix the mixture in voltex — cent for lOmin at 13000rpm 
transfer the upper layer to the new tube 
repeat step (12) 
13. Extract 1X with CHCI3 
add 2OO11I chloroform 
mix the mixture in voltex cent for lOmin at 13000rpm 
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— transfer the upper layer to the new tube 
14. Add 1/10 volume 3M NaOAc, Abs ETOH ppt. 
add 2()jiil 3M NaOAc 
+ add 400^ 1] ETOH 
cent for 15 mins at 13000rpm 
stand overnight at 4°C 
15. Wash with 70% ETOH 
+ add 500^1 70% ethanol 
voltex cent 15 min 
+ remove the supernatant 
16. Dry; resuspend in lOjil TE 
Vaccum Dry for 20min 
add 10^1 TE 
-> store at -20�C 
*PNK buffer: SOmM Tris (pH8.0), ImM EDTA, 0.5% Tween 20. 
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2.2.3 Polymerase Chain Reaction using HPV Consensus Primer 
MY09/11 
HPV consensus primer pair MY09/11 (MY09, 5'-CGT CCM ARR GGA WAC 
TGA TC-3'; MYll, 5'- GCM CAG GGW CAT AAY AAT GG -3 ' ) targeted at LI 
region of the HPV DNA to amplify about 450bp DNA sequences. (Manos et al, 1989) 
2.2.3.1 Template for PGR 
Six hundred and fourteen paraffin-embedded cervical carcinoma tissues from 
Shanghai, Sichuan, Beijing and Guangdong, and one hundred and ninety-five fresh 
cervical carcinoma tissues collected at Prince of Wales Hospital, Hong Kong, China 
were screened with MY09/11 primer set. 
2.2.3.2 PGR Amplification 
A typical 50//I reaction mixture contained 1.5mM MgCl�，100//M of each 
deoxynucleoside triphosphate, 0.25//M of each primer, 2 units of Taq polymerase 
(GIBCO BRL, Life Technologies) and 1 /z 1 of cervical cancer sample DNA. The PGR 
was performed with a modification of the original method using GeneAmp® PCR 
System 9600 or GeneAmp® PCR System 9700 (Applied Biosystems, USA) (Manos et 
al.，1989). The thermal cycling condition started at 94。C for 3 minutes for denaturation. 
Thirty-five cycles of amplification were carried as following: denaturation at 94。C for 
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30 seconds, primer annealing at 55°C for 30 seconds and primer extension at 7 2 f o r 
1 minute. After the 35 amplification cycles, 10 minutes at 72°C was for the complete 
extension of the primers. 
Several precautions were taken to prevent the false positive result and cross 
contamination. All PCR reagents were taken in aliquots from uncontaminated stock 
reagents. Different sets of pipettes and disposable sterile pipette tips were used for the 
PCR reagents and the preparation of the amplification were worked in strictly separated 
rooms. Each set of PCR included a distilled water samples as a control experiment of 
the reagents. HPV-negative human placenta DNA PCR was performed with each 
amplification reactions as a negative control for monitor sample-to-sample carried over. 
None of these control samples was positive for any of the assays. 
2.2.3.3 PCR product analysis 
The products of the reaction were electrophoresed with 2% agarose gel and stained 
with ethidium bromide running at lOOV for 1 hour in 1%TBE buffer. The PCR products 
were visualized with an ultraviolet light source and analysed by imaging system 
GelDoc 1000 byBioRad Laboratories, Inc., USA. 
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2.2.4 DNA sequencing 
Automatic sequencers did DNA sequencing, both ALYexpress DNA automatic 
sequencer AM 3.0 from Amershan Pharmacia Biotech, and ABI 377 DNA sequencer 
from Applied Biosystems were using dye primer cycle sequencing. 
2.2.4.1 DNA sequencing reaction for ALFexpress DNA automatic 
sequencer 
ALFexpress DNA automatic sequencer was designed for automatic detection of 
fluorescently labeled DNA molecules separated by electophoresis. The basic difference 
from the tranditional Sanger dideoxy sequencing method was the use of a fluorescently 
labeled primer or fluorescently labeled dNTP instead of radioactive deoxynucleotides. 
SequiTherm EXCEL™ II Long-Read ™ DNA Sequencing Kits-LC from 
Epicentre Technologies, UK was used for ALFexpress DNA automatic sequencing. 
Either Cy5™ labeled MY09 primer or Cy5™ labeled MYll primer were used in 
sequencing reactions. 
The templates for the sequencing reaction were the PCR products of MY09/11 
primer set. Microspin Column S-300 (Amerasm Pharmacia, USA) were used to purify 
50|il of PCR products; extracting the DNA from agarose gel was the other method to 
purify the templates. The PCR products were electrophoresed with 2% agarose gel and 
stained with ethidium bromide and visualized under UV light. The desired band was cut 
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by sterilize razor blade and put into the eppendorf tube. The same sample's PGR 
products were pooled in the same tube and extracted using QiAquick Gel Extraction Kit 
by Qiagen. 
In order to clean the glass plates and spacers of the ALFexpress sequencer, they 
were rinsed under room temperature running tap water with great care, as all the 
components were very fragile. Then each glass and spacer was polished by Kimwipe 
sheets, and was rinsed with 70% ethanol. This washing process was repeated for three 
times. All items were examined for any remaining gel residues and lastly Kimwipe 
sheets dried them. 
The cassette was assembled following the AUFexpress manual. The comb was 
inserted and checked that if the pressure was correct and the comb slid in too easy; if 
the pressure was uneven, changed the clamps on the loose side until an even pressure 
was reached. 
50/0 EZ Squeeze™ Gene-PAGE PLUS ™ 6M Urea sequencing gel from Amresco,, 
Ohio，USA was used for K'LVexpress autosequencing. The gel solution was warmed at 
room temperature for 10 minutes and was mixed by gentle inversion for 2 minutes with 
the ammonium persulfate TEMED polymerization catalyst and initiator disks. The 
mixed solution was poured into prepared glass plate assembly. Then let the gel solution 
polymerize at room temperature for at least 2 hours. 
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After the gel was polymerized in the cassette, mounted the cassette into 
ALFexpress, connected the water circulation and aligned the laser. Afterwards, 
carefully examined the laser beam for dust particles and for reflections on backside of 
the glass plates. The dust must be avoided by adjusting the height adjustment wheels. 2 
litres of 0.6X TBE buffer was prepared and added to the upper and lower buffer tank, 
allowing the gel to reach working temperature. Then removed the comb and rinsed the 
wells with buffer using a syringe, loaded 6 jil of each denatured samples into the wells 
starting from left in the following order: A, C, G and T followed by re-aligned the laser 
and started the run for 420 minutes. The result sequences were read and analysis using 
the evaluation programme. 
2.2.4.2 ABI comparative PCR sequencing 
ABI Prism 377 DNA Sequencer from Perkin Elmer was a fast and reliable 
sequencing method for clones screening. It runs based on the multiple fluorescent dyes 
labeled DNA cycle sequencing with AmpliTaq Polymerase, FS. The steps involved 
purifying DNA template, amplifying DNA by PCR, preparing of sequencing temple, 
performing fluorescent sequencing reaction, electrophoresizing dye-labeled samples, 
analyzing and comparing of data in gene bank. 
Purified PCR product of MY09/11 primer was used as the temple for 
auto-sequencing, 1 ^ g of template DNA was added to 3.2 pmole sequencing primer in a 
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total volume of 12 |LI1 with ddH20, then 8 )LI1 of terminator ready reaction mix from ABJ 
Prism dRhodamine Terminator Cycle Sequencing Ready Reaction Kit (Perkin Elmer, 
USA) was mixed together with the template and primer. Afterwards, underwent cycle 
sequencing on the thermal cycler and repeated the following condition sequence 25 
times: 96�C for 20 seconds, 50�C for 15 seconds and 60°C for 4 minutes. Then rapid 
thermal ramp to 4�C, spun down the contents of the tubes in a microcentrifuge. Excess 
dye terminators were removed by ethanol precipitation. For 20 |LI1 PCR reaction, 2 jul of 
3M sodium acetate (pH 4.6) and 50 \i\ of 95% ethanol were added. Vortex the tubes 
and placed on ice for 3 hours to precipitate the extension products. Then spun the tubes 
in a microcentrifuge at 13,000 rpm for 20 minutes at 4�C，carefully aspirated the 
supernatant with a pipette and discard, rinsed the pellets with 250 jil of 70% ethanol. 
Spun for another 5 minutes, carefully discards the supernatant, and dried the pellet in a 
vacuum centrifuge for 15 minutes. 
In order to store the samples, each sample was resuspended in 12 jul of Template 
Suppression reagent (TSR). Before the reaction started, the samples in TSR were vortex 
and spun. The DNA were denatured by heating at 95�C for 2 minutes, it then chilled on 
ice until ready for use. 
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2.2.4.3 DNA sequence analysis 
GCG package (version 8.0) from Genetics Computer Group Inc. was currently 
installed in the network system in The Chinese University of Hong Kong. The DNA 
sequences obtained from the sequencing of screening clones were directly input into the 
GCG program. Data searching of the entire HPV gene was performed by the FASTA 
command. They were then retrieved into the computer for further manipulation. Any 
updated sequences was download directly from the internet website of the Genebank 
(http://www.ncbi.nlm.nih.gov 
2.2.5 Restriction Fragment Length Polymorphism 
RFLP is a molecular biology technique using the restriction enzymes to cut the 
DNA sequences into short fragments. Restriction enzymes have the ability to cut the 
nucleotides according to unique DNA sequence. Each type of HPV have its own DNA 
sequences so using specific restriction enzymes can produced unique patterns. 
Double infection of HPV could detect using RFLP technique. If the specimen 
infected by 2 types of HPV, MY09/11 primer pair could amplify both types of HPV 
DNA. In this case, both type's digestion pattern could detected. 
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2.2.5.1 Template preparation 
The templates for Restriction Fragment Length Polymorphism (RFLP) were the 
PCR product of MY09/11 primer set. Five micro littlers of the crude PCR products 
were used in the RFLP. 
2.2.5.2 Restriction enzyme digestion 
Aliquots of the PCR products were subjected to digest with restriction enzyme Rsa 
I and Dde I (SuRE/Cut Buffer Set; Boehringer-Marmheim). Five units of enzymes were 
mixed with its specific buffer in total volume 10//1. Reactions were incubated in a 
37°C water bath for 1 hour. 
2.2.5.3 Agarose gel electrophoresis analysis 
The products of the reaction were electrophoresed with 3% agarose gel stained 
with ethidium bromide run at 50V for 1 hour in 1% TBE buffer. The digestion products 
were visualized with an ultraviolet light source and analysis by imaging system GelDoc 
1000 by BioRad Laboratories Inc. The sizes of the restriction enzyme digestion 
products were confirmed with reference to the DNA standard size marker. 
Chapter 2: Materials and Methods 
2.2.6 HPV Type Specific PCR 
Since the PCR carried out on crude samples was easy to perform, HPV type 
specific PCRs developed and applied to a variety of clinical specimens. HPV type 
specific primers targeted in several parts of the HPV genomes and could be synthesized 
in large amounts. 
2.2.6.1 Preparation of positive control DNA 
There were total six types of HPV type specific primers, HPV 16, HPV 18, HPV 
31, HPV 33, HPV 52 and HPV 58. (Table 2.1) The positive control DNA of HPV 16， 
HPV 31 and HPV 33 PCR were cervical carcinoma tissues collected from Hong Kong. 
They were screened by MY09/11 and typed with RFLP and DNA sequencing to 
confirm the presence of HPV 16, HPV 31 and HPV 33 DNA. HeLa cell was used as 
positive control of HPV 18 PCR. 
2.2.6.2 Preparation of HPV 52 and HPV 58 type specific PCR 
Plasmids of HPV 52 and HPV 58 were kind gifts of Prof. Wayne Lancaste and 
Prof. Toshihiko Matsukura respectively. HPV 52 plasmids were directly transformed 
with JM 109 High Efficiency Competent Cells (Promega, USA). At first thawed the 
vials of JM109 Competent ncells on ice. Then, 2 i^l of HPV 52 plasmid reacted into the 
competent cells and stirred gently with pipette tip to mix. In order to heat shock the 
cells，the vials containing the cells were incubated on ice for 30 minutes and then 
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placed in a 42°C water bath for exactly 30 seconds. Next immediately placed the vials 
on ice for 2 minutes and added 450 |LI1 of SOC medium to each vial, shaked the vials at 
37°C in a shaker at 220 rpm for 1 hour. The transformed cells were then plated 50 ^l, 
100|Lil and 200 i^l on an LB plate containing 50 |Lig/ml ampicillin, 20 jul X-Gal and 50 
IPTG. Incubated the plates at 37°C overnight, and shifted the plates to 4 � C for colour 
development. Plasmid DNA was isolated from 3 white transformants and analyzed for 
the presence and HPV 52 DNA by RFLP. 
For HPV 58 sequence, additional of A-tail sequence to the genome was performed. 
2jLil of the HPV 58 genome were added to the 1|LI1 of Taq DNA polymerase lOX 
reaction buffer with MgCh. Total 0.2mM dATP and 5U of Taq DNA Polymerase were 
added to the reaction mixture. 
pGEM-T Vector System from Promega was used for the cloning of HPV 58 
sequence from the original HPV 58 genome. Ligation reaction was set up by adding 1 
III of the fresh genome ( � 1 0 ng) into 1 |LI1 pGEM-T vector (50 ng/^1), 5 |LI1 2 X rapid 
ligation buffer and 1 |LI1 T4 DNA ligase in a volume of 10 lul with ddHsO，incubated at 
14 °C overnight for the ligation reaction. In the following day, transformation was done 
as the same as HPV 52 plasmid preparation. 
Small-scale preparation of plasmid DNA, better known as minipreps was done 
by Wizard™ minipreps DNA purification system (Promega, USA). Each miniprep 
started from a 3ml LB medium containing 50 ^g / ml ampicillin overnight culture in 15 
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ml culture tubes, which were the selected white recombinants colonies containing the 
pGEM-T vector with the genome as inserted. Allowed the culture to grow at 37°C with 
shaking at 250 rpm overnight. 
The cultured cells were collected by centrifugtion for 10 minutes at 2000 rpm at 
4°C. Resuspended the cell pellet in 200 jul cell resuspension solution (50 mM Tris-HCl 
(pH 7.5 ), 10 mM EDTA, 100 |Lig/ml RNase A). Then transferred the resuspended cells 
to an 1.5ml eppendorf tube. Added 200 jil of cell lysis solution (0.2 M NaOH，1% SDS) 
and mixed by gently inverting the eppendorf for several times until it turned to clear. 
Afterwards, added 200 jul of neutralization solution and mixed by inverting the 
eppendorf several times. Spun at 13,000 rpm for 5 minutes at room temperature, then 
decanted the clear supernatant to a new centrifuge tube. 
Added 1 ml of the Wizard^^ minipreps DNA purification resin to the clear 
supernatant and mixed by inverting the tube. For each miniprep, prepared one new 
Wizard™ minicolumn. 
The resin / DNA mix were pipetted into the minicolumn, spun at 13,000 rpm for 
1 minute. In order to wash the minicolumn, 2 ml of column wash solution (200 mM 
NaCl，20 mM Tris-HCl (pH 7.5 ), 5 mM EDTA in 55% ethanol ) were used. Finally 
transferred the minicolumn to a new centrifuge tube, applied 50 |li1 of water to the 
minicloumn and waited for 1 minutes. To elute the DNA, spun at 13,000 rpm for 1 
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minute at room temperature, then removed and discarded the minicolumn, stored the 
plasmid DNA in eppendorf at -20°C for future used. 
2.2.6.3 PCR primer design 
The primer sequence for HPV 16, HPV 18，HPV 31, HPV 33 were adopted from 
Baay 1996. (Table 2.1) 
The sequence of the HPV 52 and HPV 58 specific oligonucledtide primers were 
newly designed used to amplify a unique region of the boundary of the E7 and Ei 
proteins and was based on the published sequences of the HPV genome. The sequences 
were chosen with the aid of computer programmes and the comparison with existing 
sequences in the gene bank. Primers sequences for HPV 52 (5'-
GCATTCATAGCACTGCCAC - 3，； 5, - GCCTCTACTTCAAACCAGCC - 3,) 
corresponded to position of the sense strand 761 - 779 and antisense strands 909 — 928. 
This primer pairs produced an amplified product of 168 bases. 
HPV 58 type specific primers sequences corresponded to position 833 - 851 of 
sense strand (5' - CATGTACCATTGTGTGCCC — 3，）and position 932 — 950 of 
antisense strand (5' — ACCGCTTCTACCTCAAACC — 3,). This pair of primers gave 
118 bases of the amplified product. The sequences of the probes for confirming the 
amplicons in Southern Hybridization were designed within the amplified sequence. The 
oligonucleotide sequences were: HPV 52: 5'- ACACAACTTGTAATGTGCCC — 3,; 
HPV 58: 5,- TGCACAGCAATAAACACATC - 3’. 
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Table 2.1 Different HPV type specific primers sequences 
D . . ^ Amplimer 
Pnmer pair Sequence 
length (bp) 
HPV 16 sense * 5，- GGT CGG TGG ACC GGT CGA TG - 3， 
96 
HPV 16 antisense * 5'- GCA ATG TAG GTG TAT CTC C A - 3 ' 
HPV 18 sense * 5 ' - CCT TGG ACG TAA ATT TTT GG - 3, 
115 
HPV 18 antisense * 5 ' - CAC GCA CAC GCT TGG CAG G T - 3 ' 
HPV 31 sense * 5 ' - GGG ATT GTT AGA AAA GCT ACC — 3， 
110 
HPV 31 antisense * 5 ' - CGC TTA GTA GAC GTC GTC G C - 3 ' 
HPV 33 sense * 5，- CCA CCA CTG CTT CTT ACC TC - 3, 
114 
HPV 33 antisense * 5 ' - ACC ATT TTC ATC AAA TGG G A - 3 ' 
HPV 52 sense 5，- GCA TTC ATA GCA CTG CCA C - 3， 
168 
HPV 52 antisense 5，- GCC TCT ACT TCA AAC CAG CC - 3， 
HPV 58 sense 5' - CAT GTA CCA TTG TGT GCC C - 3， 
118 
HPV 58 antisense 5' - ACC GCT TCT ACC TCA AAC C - 3， 
* Journal of Clinical Microbiology, Mar. 1996，p.745-74 
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2.2.6.4 PCR Amplification 
PCR amplification conditions of HPV 16, 18，31 and 33 were similar to 
MY09/11 PCR amplification. A typical 50// 1 reaction mixture contained 1.5mM 
MgCl2, 100//M of each deoxynucleoside triphosphate, 0.25 /zM of each primer, 2 
units of Taq polymerase (GIBCO BRL, Life Technologies) and 1 //1 of cervical cancer 
sample DNA. The thermal cycling condition was started at 94°C for 3 minutes for 
denaturation. Thirty-five cycles of amplification were carried as follows: denaturation 
at 94°C for 30 seconds, primer annealing at 55°C for 30 seconds and primer extension 
at 72�C for 1 minute. After the 35 cycles amplification, 10 minutes at 72°C was for the 
complete extension of the primers. 
For PCR amplification of HPV 52 and HPV 58, a typical 50 //1 reaction mixture 
contained l.SmM MgCb, 100//M of each deoxynucleoside triphosphate, 0.25//M of 
each primer, 2 units of Taq polymerase (GIBCO BRL, Life Technologies) and 1 //1 of 
cervical cancer sample DNA. The PCR condition was performed with a modification of 
the original method (Saiki et al., 1988). The thermal cycling condition was started at 94 
t： for 3 minutes for denaturation. Thirty-five cycles of amplification were carried as 
follows: denaturation at 94�C for 30 seconds, primer annealing at 59°C for HPV 52 
and 62°C for HPV 58 for 30 seconds and primer extension at 72�C for 1 minute. After 
the 35 cycles amplification, 10 minutes at 72°C was for the complete extension of the 
primers. The products of the reaction were electrophoresed on 2% agarose gel and 
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Stained with ethidium bromide in TBE buffer running at lOOV for 1 hour. The PCR 
products were visualized with an ultraviolet light source. 
Southern hybridization analysis was used to confirm the HPV 52 and HPV 58 type 
specific PCR. An aliquot (25 [i 1) of the PCR products was electrophoresed on 2% 
agarose gel and was then used for Southern blot analysis. The gel was shaken twice 
with 0.4 M NaOH, IM NaCl for 15 minutes and 20 minutes respectively, and then 
rinsed with ddH20. A piece of nylon membrane (Hybond-N, Amersham) was cut and 
put on top of the gel. At the bottom of the gel, a paper bridge with 3 MM Whatman 
paper was set up and 0.4 M NaOH, IM NaCl was used for overnight transfer. The 
following day, the membrane was baked for 2 hours in 80°C oven for fixing the DNA 
on the membrane. Membrane was prehybridised in 10ml of prehybridization solution 
containing 5X Denhardt's reagent, 6X SSC (IX SSC = 0.15M NaCl, 0.015M sodium 
citrate，pH 7.0), 0.1% sodium dodecyl sulphate (SDS) and 100//g/ml of denatured 
salmon sperm DNA for 2 hours at 50�C, and hybridized in the same buffer containing 
0.5 pmol/ml of a purified [ y -^ ^P] ATP 5' end-labeled oligonucleotide probe (2 x 10^  
cpm/ml) overnight at Tm -10�C. Membrane was rinsed briefly in 2X SSC, 0.1% SDS at 
room temperature and then twice for 10 minutes at 40�C; IX SSC, 0.1% SDS four 
times at room temperature for 5 minutes each and O.IX SSC, 0.1% SDS twice at room 
temperature for 10 minutes. The membranes were exposed to X-ray film (Kodak 
Biomax MS) in a cassette with intensifying screen for 6 hours at -80�C. 
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Fig 2.1. Set up of Southern Hybridization 
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2.2.7 Polymerase Chain Reaction using HPV Consensus Primer 
GP5+/6+ 
HPV consensus primer GP5+/6+ (GP5+, 5’-TTT GTT ACT GTG GTA GAT ACT 
AC- 3，； GP6+，5'- GAA AAA TAA ACT GTA AAT CAT ATT C-3') targets at LI 
region of the HPV DNA to amplify about ISObp DNA sequences. This primer set 
consists of a fixed nucleotide sequence for each primer and detects a wide range of 
HPV types, (de Roda et al” 1995) 
2.2.7.1 Template for PCR 
One hundred and forty four paraffin-embedded cervical carcinoma tissue blocks 
from Shanghai, Sichuan, Beijing and Guangdong were screened with GP5+/6+ primer 
set. 
2.2.7.2 PCR Amplification 
A typical 50//I reaction mixture contained 1.5mM MgCl�，100/zM of each 
deoxynucleoside triphosphate, 0.25 " M of each primer, 2 units of Taq polymerase 
(GIBCO BRL, Life Technologies) and I fxl of cervical cancer sample DNA. The 
thermal cycling condition was started at 94�C for 3 minutes for denaturation. 
Thirty-five cycles of amplification were carried as follows: denaturation at 95°C for 1 
minute，primer annealing at 42�C for 1 minute and primer extension at 72�C for 1 
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minute. After the 40 cycles amplification, 10 minutes at 72°C was for the complete 
extension of the primers. 
2.2.7.3 PCR product analysis 
The products of the reaction were electrophoresed with 2% agarose gel and stained 
with ethidium bromide in TBE buffer run at 50V for 2 hour. The PCR products were 
visualized with an ultraviolet light source and analysis by imaging system GelDoc 1000 
by BioRad. 
2.2.8 Statistical analysis 
Statistical analysis of the comparison in terms of HPV type and histology was 
performed using the JUMP IN for Windows (SAS Institute). Chi-square test and 
Fisher's Exact test were done to assess statistical significance for the difference in the 
prevalence of HPV types by the histologic type of cervical cancer and the viral type and 
geographic region. 
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CHAPTER 3 
RESULTS 
3.1 Histology review of tumor specimens 
A total 863 tumor specimens, including paraffin-embedded and snap frozen 
tissue blocks, were sectioned and stained with H&E. Dr. May Chan and Prof. Y.F. 
Wong of the Chinese University of Hong Kong reviewed the histologic type and grade 
of differentiation of the specimens (Table 3.1 and 3.2). Among those specimens, 
thirty-three specimens from Shanghai, twenty specimens from Sichuan and one from 
Beijing were excluded from the study as no cancer cells were found in the 
corresponding slides. 
With regard to patient population, 729 (90.1%) patients were diagnosed as 
squamous cell carcinoma; 64 (7.9%) as adenocarcinoma; 10 (1.2%) as adenosquamous 
carcinoma and 6 (0.8%) with other diagnosis. The results of grading were as follows: 
grade 1, 218 (26.9%); grade 2, 416 (51.4%) and grade 3, 175 (21.7%). 
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Table 3.1 Histologic types of cervical carcinoma tissues from different regions of 
China 
— Hong 
H i s t o 丨 S h a n g h a i Sichuan Beijing Guangdong ^^^^ 
Squamous 146 146 150 125 162 
Adenocarcinoma 3 11 0 21 29 
Adenosquamous 1 3 0 3 3 
Small-cell 
IT 八 r ‘ 、 J 0 2 0 2 1 Undifferentiated 
Clear Cell 
. . 0 1 0 0 0 Adenocarcinoma 
Total 150 163 150 151 195 
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Table 3.2 Histologic grades of cervical carcinoma tissues from different regions of 
China 
Regions 
Shanghai Sichuan Beijing Guangdong 彻 ng 
Differentiation*^. Kong 
Grade 1 39 27 30 75 47 
Grade 2 80 75 104 54 103 
Grade 3 31 61 16 22 45 
Total 150 163 150 151 195 
* Grade 1: well differentation 
Grade 2: moderate differentation 
Grade 3: poorly differentation 
Chapter 3: Results 丨).76 
3.2 Polymerase chain reaction using HPV consensus primer MY09/11 
PCR using HPV consensus primer MY09/11 was used for screening of HPV 
genome in the cervical carcinoma tissues. HPV amplification products of the expected 
size (~450bp) were observed in ethidium bromide stained gel (Fig.3.1). A total 809 
paraffin-embedded and fresh cervical carcinoma tissues were subjected to this 
screening. A total 451 specimens were shown positive in this PCR including 88 out of 
150 (58.67%) specimens from Shanghai; 54 out of 163 (32.1%) specimens from 
Sichuan; 52 out of 150 (34.7%) specimens from Beijing; 104 out of 151 (68.8%) 
specimens from Guangdong and 153 out of 195 (78.4%) specimens from Hong Kong 
showed positive results in this PCR. From the above, it was obvious that the efficiency 
of MY detection in Sichuan was lower than Hong Kong (p=0.00) 
Serial dilution test was carried out to determine the sensitivity of HPV detection 
using primer pair MY09/11. HeLa cells, which contained 10-50 copies of HPV 18 
genome in the cell, were used as the template of PCR. The DNA extracted from Hela 
cells were used in the dilution test in which 100,000 Hela cells were used for this test. 
Then, 10,000 Hela cells were used for the test. After that 5,000 Hela cells followed by 
1,000 Hela cells, 500 Hela cells, 100 Hela cells, 50 Hela cells, 10 Hela cells, 5 Hela 
cells until 1 Hela cell were used for the test. In fact, the lowest limit of this PCR was 1 
copy of Hela cell, the lowest limit of this PCR was 1 copy of HeLa cell (Fig. 3.2). 
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PCR using beta actin primer 
The P-actin PCR was performed to access the integrity of DNA. A total 358 
specimens that were negative after the test of MY PCR would be used to amplify a 
DNA fragment at 303bp within the P-actin region and they were found to be visible in 
ethidium bromide stained gels. (Fig. 3.3) 
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Fig. 3.1 Electrophoresis of PCR products from LI region of HPV genome in 
cervical carcinoma tissues in agarose gel stained with ethidium bromide. 
Lane 1: HPV DNA positive sample; Lane 2: positive control using HeLa 
cell DNA; Lane 3: negative control of DNA isolated from human 
placenta; Lane 4: negative control of distilled water; M: size marker, 
a)x-174/HaeIII Markers. 
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Fig 3.2 HPV PCR products of HeLa cells using MY09/11 primer pair in 2% 
ethidium bromide stained agarose gel. Lane 1，100,000 HeLa cells; Lane 2， 
10,000 HeLa cells; Lane 3，5,000 HeLa cells; Lane 4，1,000 HeLa cells; Lane 
5，500 HeLa cells; Lane 6，100 HeLa cells; Lane 7，50 Hela cells, Lane 8，10 
HeLa cells; Lane 9，5 HeLa cells; Lane 10, 1 HeLa cell; Lane 11, Human 
plasma cells as negative control of this PCR, M, size marker Ox-174/HaeIII 
Markers. 
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Fig. 3.3 Electrophoresis of PCR products from p actin region of human genome 
in 2% agarose gel stained with ethidium bromide. Lane 1: Human 
placenta DNA as positive sample; Lane 2: negative control of distilled 
water; M: size marker a)x-174/HaeIII Markers. 
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3.3 DNA sequencing reaction 
There were 451 cervical carcinoma specimens, which were positive with MY09/11 
PCR undergoing DNA sequencing reaction. HPV typing was obtained in 283 
specimens including 23 (26.1%) samples from Shanghai, 30 (55.6%) samples from 
Sichuan, 20 (38.5%) from Beijing, 71 (68.3%) from Guangdong and 138 (90.2%) from 
Hong Kong. The efficiency of DNA sequencing in Guangdong and Hong Kong was 
statistically higher than that in Shanghai and Sichuan (p=0.00 by Fisher's exact test) 
Ten types of HPV were detected in the cervical carcinoma tissues. These included 
HPV 11，HPV 16，HPV 18, HPV 31, HPV 33. HPV 45, HPV 52, HPV 58 and HPV 70. 
Besides HPV 11 which was low risk HPV type, the rest were high or intermediate risk 
HPV types. The detection of HPV 16 in DNA sequencing successful specimens were 
found in 21 of 23 (91.3%) in Shanghai; 26 of 30 (86.7%) in Sichuan; 17 of 20 (85%) in 
Beijing; 52 of 72 (72.2%) in Guangdong and 85 of 153 (55.6%) in Hong Kong. HPV 16 
detection rate was predominated in most of the regions except Hong Kong (p=0.1653 
by Fisher's exact test) The infection of HPV 18 were found in 2 (8.6%) specimens in 
Shanghai; 3 (10%) in Sichuan; 1 (5%) in Beijing; 5 (7%) in Guangdong and 20 (14.4%) 
in Hong Kong. (Table 3.3) 
The sequencing results obtained from 150 to 410 nucleotides were compared to 
known HPV sequences available in the genebank. The aligned sequences of HPV 16 
(sample from Sichuan), HPV 58 (sample from Guangdong) and HPV 18 (sample from 
Shanghai) were shown in Fig. 3.4 — Fig 3.6, respectively. 
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Table 3.3 HPV typing results using DNA sequencing with MY09/11 primer pair 
HPV type^^""^^--^ Shanghai Sichuan Beijing Guangdong Hong Kong 
11 0 0 0 1 2 
16 21 26 17 52 85 
18 2 3 1 5 20 
31 0 0 0 2 1 
33 0 0 0 0 9 
45 0 0 0 2 0 
52 0 0 0 4 8 
53 0 0 0 0 1 
58 0 1 2 6 11 
70 0 0 0 0 1 
Total typed samples 23 30 20 72 138 
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3.4 Restriction fragment length polymorphism 
Total 169 paraffin-embedded and frozen cervical carcinoma tissues were 
re-amplified with MY09/11 and typed using RFLP. 145 (85.7%) samples gave 
recognizable digestion patterns of HPV DNA (Fig 3.7 — Fig 3.8) and 24 samples were 
still untyped. These 24 samples were then analyzed again by using HPV type specific 
primer PCRs. 
Five types of HPV were detected in the cervical carcinoma specimens using RFLP. 
These included HPV 16, HPV 18, HPV 33，HPV 52 and HPV 58. The detection of 
HPV 16 in the cervical carcinoma tissues were 91% (34/37) in Shanghai; 100% (5/5) in 
Sichuan; 92.3% (72/78) in Beijing; 100% (6/6) in Guangdong and 75% (15/20) in Hong 
Kong. There was no statistically significant difference in different regions (p-0.1325 by 
Fisher's exact test). (Table 3.4) 
Double infection of HPV 16 and HPV 58 was detected in one sample from 
Shanghai. 
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Table 3.4 Results of HPV typing using RFLP 
^•^-.^Regions 
H P V t y p e s \ . Shanghai Sichuan Beijing Guangdong Hong Kong 
16 34 5 72 6 15 
18 0 0 3 0 4 
33 0 0 0 0 1 
52 0 0 2 0 0 
58 3* 0 1 0 0 
Total 37* 5 78 6 20 
* Double infection of HPV 16 + HPV 58 was counted 
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Figure 3.7 Restriction fragment length polymorphism patterns of MY09/11 LI 
PCR products used to identify genital HPV types. Electrophoresis of 
restriction enzyme Rsa I digestion of different PCR products in 2% 
agarose gel stained with ethidium bromide. Lane 1: HPV 16 (310bp, 
72bp，70bp) ； Lane 2: HPV 18 (135bp, 125bp, 85bp, 72bp, 38bp); 
Lane 3: 31 (380bp, 72bp) ； Lane 4: HPV 33 (236bp, 102bp, 72bp, 
39bp); Lane 5: HPV 52 (449bp) ； Lane 6: HPV 58 (306bp, l l lbp , 
32bp); Lane 7: size marker �x-174/HaeIII Markers. 
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Figure 3.8 Restriction fragment length polymorphism patterns of MY09/11 LI 
PCR products used to identify genital HPV types. Electrophoresis of 
restriction enzyme Dde I digestion of different PCR products in 2% 
agarose gel stained with ethidium bromide. Lane 1: HPV 16 (452bp); 
Lane 2: HPV 18 (432bp，23bp); Lane 3: HPV 31 (283bp, 167bp, 2bp); 
Lane 4: HPV 33 (320bp, 77bp, 52bp); Lane 5: HPV 52 (357bp, 92bp); 
Lane 6: HPV 58 (348bp, lOlbp); Lane 7: size marker <Dx-174/HaeIII 
Markers. 
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3.5 HPV type specific polymerase chain reaction 
The band size of HPV 16, 18, 31, 33, 52 and 58 positive samples was %bp, llSbp, 
llObp, 114bp, 168bp and 118bp respectively. HPV DNA was identified in 227 out of 
371 (61%) specimens. (Fig. 3.9) 
There were 128 specimens from Sichuan and after screening, 105 (82%) out of 
them showed positive. No evidence of any HPV DNA presented in the specimens from 
Hong Kong. In Shanghai, Beijing and Guangdong, the positive rates were 61%, 41% 
and 61% respectively. This showed that the HPV type specific primers PGR was 
efficient in detecting the HPV types in Sichuan specimens and least effective in Hong 
Kong specimens from Hong Kong. 
HPV 16 infection was the most common type found in this screening and 202 
specimens were found to be infected. The difference was not statistically significant 
(p=0.364 by Fisher's exact test) in different regions of HPV 16 infection. There were 14 
specimens infected by HPV 18, 4 specimens by HPV 52 and 2 specimens by HPV 58. 
Among the specimens with HPV infection there were 2 specimens having more 
than one type of HPV infection including one case with HPV 18/52 in Sichuan, and 
another case with HPV 18/31 in Guangdong. (Table 3.5) 
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Table 3.5 Results of HPV typing using HPV type specific primers PCR 
^ \ ^ R e g i o n s Hong 
TT九TT ^ ^ Shanghai Sichuan Beijing Guangdong 
HPV t y p e ^ ^ 各 J 各 各 谷 Kong 
16 50 91 21 40 0 
18 2 9* 0 3* 0 
31 2 0 0 1* 0 
33 1 1 0 0 0 
52 1 2* 0 1 0 
58 0 2 0 0 0 
Total No. of 
^ ^ 56 104 21 44 0 
typed sample 
Total screened 91 128 51 73 28 
* Double infections of HPV 52 + HPV 18 and HPV 18 + HPV 31 were counted 
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Figure 3.9 Electrophoresis of HPV type 18 specific PCR in 2 % agarose gel 
stained with ethidium bromide. Lane 1: HeLa cell DNA; Lane 2 HPV 
18 specimen from Sichuan; M: size marker a)x-174/Haem Markers 
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HPV 52 and 58 type specific polymerase chain reaction 
Primers for HPV 52 and 58 type-specific polymerase chain reactions were newly 
designed for this study. Prof. Wayne Lancaster and Prof. Toshihiko Matsukura kindly 
provided the HPV 52 plasmid and HPV 58 genome respectively. 
Transformation of HPV 52 and 58 plasmids were done to produce enough HPV 52 
and HPV 58 DNA for the development of HPV type-specific primers. The 
transformation efficiency of HPV 52 plasmids was 100% and it was 70% for HPV 58. 
HPV 52 plasmid DNA was extracted and digested with EcoR 1. The 8kb-size 
DNA was the genome of HPV 52 while the 3kb-size DNA was the cloning vector. Ncol 
and Not I were used to digest the HPV 58 plasmid into the 8kb-size DNA (HPV 58 
genome) and 3kb-size DNA (pGEM-T vector) (Figure 3.10) 
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Fig 3.10 DNA extracted from HPV 52 and HPV 58 plasmid. Lane 1: HPV 58 
plasmid digested with Nco I and Not I; Lane 2 and 3: HPV 52 plasmid 
digested with EcoR I; Lane 4: Uncut HPV 58 plasmid; Lane 5 and 6: 
Uncut HPV 52 plasmid, M: size marker Lambda DNA/Hind III 
Markers 
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Specificity of the reaction 
Five different types of HPV DNA (HPV 16, HPV 31, HPV 33，HPV 52, HPV 
58) and HeLa cells, which were used as a positive control of HPV 18, were used in 
different PGR to determine the specificity of the primers. HPV 52 yielded a band of 
168bp and there was no this band appearing in all the rest of the samples. A band of 
118bp was only observed in the PGR with HPV 58 DNA but could not be observed in 
other types of HPV DNA. (Fig. 3.11) 
Southern hybridization was performed with 5'-end labeling method. After gel 
electrophoresis, PGR products were transferred onto the nylon filter membranes by 
Southem-blot. Then, the membranes were hybridized with a HPV 52 and HPV 58 
32 
P-labelled oligonucleotide probes respectively. (Fig 3.12) 
Sensitivity of the methods 
The sensitivity of the PGR was determined by HPV DNA serial dilution test. The 
PCRs were started with 1 ng of HPV 52 and HPV 58 plasmid DNA with serial ten-fold 
dilutions. The lowest limit of HPV DNA detection in PCRs was lOfg of HPV DNA. 
(Fig. 3.13-3.16) 
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Fig 3.11 Detection of HPV 58 DNA using HPV 58 type specific PCR with other 
types of HPV infected cervical cancer specimens. PCR products were 
shown after electrophoresis on 2% agarose gel and ethidium bromide 
staining. Lane 1-6; HPV 16，HPV 18，HPV 31，HPV 33，HPV 52 and HPV 
58 DNA respectively. Lane 7: negative control of DNA isolated from 
human placenta; Lane 8: negative control of distilled water; M: size 
marker, (I>x-174/HaeIII Markers. 
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Fig 3.12 Southern hybridization of HPV 58 DNA transferred from the agarose gel 
in Fig. 3.11 using a [ r -^ ^P] labeled HPV 58 type specific probe. The 
arrow indicated the HPV 58 positive case. 
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Fig 3.13 Sensitivity of the HPV 52 type specific PCR. Lane 1-8: amplification 
products of several 10-fold dilution of HPV 52 plasmid DNA, from lOng, 
lane 1 to 1 fg, lane 8 were analysed on 2% agarose gel stained with 
ethidium bromide. Lane 9: negative control of DNA isolated from 
human placenta; Lane 10: negative control of distilled water; M: size 
marker, a>x-174/HaeIII Markers. 
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Fig 3.14 Southern hybridization of HPV 52 DNA transferred from the agarose gel 
in Fig. 3.13 using a [ r -^ ^P] labeled HPV 52 type specific probe. The 
arrow indicates the HPV 58 positive case. The lane arrangement was the 
same in Fig. 3.13 
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Fig 3.15 Sensitivity of the HPV 58 type specific PCR. Lane 1-8; amplification 
products of several 10-fold dilution of HPV 58 plasmid DNA, from lOng， 
lane 1 to 1 fg, lane 8 were analysed on 2% agarose gel stained with 
ethidium bromide. Lane 9: negative control of DNA isolated from 
human placenta; Lane 10: negative control of distilled water; M: size 
marker, €>x-174/HaeIII Markers. 
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Fig 3.16 Southern hybridization of HPV 58 DNA transferred from the agarose gel 
in Fig. 3.15 using a [ r -^ ^P] labeled HPV 58 type specific probe. The 
arrow indicated the HPV 58 positive case. The lane arrangement was the 
same in Fig. 3.15. 
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Validation on snap-frozen tissues and paraffin-embedded clinical specimens 
The HPV 52 and HPV 58 type specific PCR were tested on paraffin-embedded 
and fresh tissues. There were 5 fresh samples and 3 out of 4 paraffin-embedded tissues 
shown positive with HPV 52 type specific PCR whereas there were 6 fresh samples and 
4 paraffin-embedded tissues showing positive for HPV 58 type specific PCR. The 
results showed that the efficiency of these 2 types specific PCR were high. (Fig 3.17 -
3.20) 
Comparison of HPV consensus primers and type specific primers 
There were 15 and 10 specimens of HPV 58 and HPV 52 respectively, showed 
positive in this study. 3 out of 15 (20%) HPV 58 positive specimens and 6 out of 10 
(60%) HPV 52 positive specimens were MY09/11 negative. The sensitivity of the 
MY09/11 PCR was 10 copies of HPV DNA. All the specimens after the use of 
MY09/11 and GP5+/6+ primers were negative but positive to HPV 52 and 58 
type-specific primers were paraffin-embedded tissues. This result showed that the HPV 
52 and HPV 58 type-specific primers were more sensitive in paraffin-embedded 
specimens than MY and GP+ primer sets. (Fig. 3.21 — 3.22) 
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Fig. 3.17 HPV 52 type specific PCR. Lane 1-5: analysis of fresh prepared cervical 
cancer DNA from 5 different patients; Lane 6-8: analysis of 4 
paraffin-embedded cervical cancer tissue biopsies; Sample 6 was 
negative for HPV 52; Lane 9: positive control of HPV 52 plasmid; 
Lane 10: negative control of Hela cell DNA. Lane 11: negative control of 
distilled water. 
Chapter 3; Results ]' 10 ： 
11 10 9 8 7 6 5 4 3 2 1 
、：* 
• ’•. 變‘翁， ^ 168bp 
Fig 3.18 Southern hybridization of HPV 52 DNA transferred from the agarose gel 
in Fig. 3.17 using a [ r -^ ^P] labeled HPV 52 type specific probe. The 
arrow indicated the HPV 52 positive case. The lane arrangement was the 
same in Fig. 3.17 
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Fig. 3.19 HPV 58 type specific PCR. Lane 1-6: analysis of fresh prepared cervical 
cancer DNA from 6 different patients; Lane 7-10: analysis of 4 
paraffin-embedded cervical cancer tissue biopsies; Lane 11: positive 
control of HPV 58 plasmid; Lane 12: negative control of distilled water 
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Fig 3.20 Southern hybridization of HPV 58 DNA transferred from the agarose 
gel in Fig. 3.19 using a [ r -^ P^] labeled HPV 58 type specific probe. The 
arrow indicated the HPV 58 positive case. The lane arrangement was 
the same in Fig. 3.19 
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Fig 3.21 Comparison of PCR using HPV 58 type specific primer, MY09/11 and 
Gp5+/6+ in paraffin-embedded HPV 58 samples. Lane 1，4，7: HPV 58 
type specific primer; Lane 2，5，8: MY09/11 primer; Lane 3，6，9: GP 
5+/6+ primer; Lane 10: HPV 58 type specific primer with HPV 58 
plasmid; Lane 11: MY09/11 primer with HPV 58 plasmid (450bp); Lane 
12: GP5+/6+ primer with HPV 58 plasmid; Lane 13-15: negative control 
of distilled water for each set of PCR. 
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Fig 3.22 Comparison of PCR using H P \ 52 type specific primer, M^ 09/11 and 
in parafrin-cmbcdclecl m ) V 52 samples. Lane 1, 4, 7,10, 13, 16: 
IIPV 58 type specific primer. I.ane 2, 5, 8, 14, 17: :VIY0()/11 primer. 
Lane 6, 9,12,15,18: C;P 5+/6+ primer. Lane 19: H P \ 52 type specific 
p r i m e r � � i t h H P \ 52 plasmid. Lane 20: M^'OWIl primer with IIP\ 52 
|)lasmitl (450hi)). I,ant. 21: p r i m e r � �i t h H P \ 52 plasmid. I.arie 
iuj:ati \c control of distilied water for each set of P( K. 
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3.6 Polymerase Chain reaction using HPV consensus primer GP5+/6+ 
Total 144 cervical carcinoma specimens that were negative with MY primer DNA 
sequencing, RFLP and HPV type specific primers PCR were screened with HPV 
consensus primer pair GP5+/6+. 17 specimens were detected with HPV DNA among 
which 3 (8.5%) from Shanghai, 3 (13%) from Sichuan, 4 (13%) from Beijing, 3 (10.7%) 
from Guangdong and 4 (14.2%) from Hong Kong (Fig 3.23). 
Five types of HPV were detected in the 17 cervical carcinoma tissues using DNA 
sequencing with GP5+/6+ primer pair. The sequencing results obtained from 90 to 120 
nucleotides were compared to known HPV sequences available in the genebank. These 
included HPV-16, HPV 35. HPV 45, HPV 59 and HPV 67. Except HPV 16 which was 
high risk HPV type, the rest were intermediate risk HPV types. HPV 16 were detected 
in 1 specimen from Sichuan, Beijing and Guangdong respectively. (Table 3.6) 
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Table 3.6 Results of GP5+/6+ PCR screening and HPV typing by DNA sequencing 
using GP5+/6+ primer pair 
HPV Shanghai Sichuan Beijing Guangdong Hong Kong 
16 0 1 1 1 0 
35 0 0 0 0 1 
45 0 0 1 0 0 
59 1 2 0 2 2 
67 0 0 0 0 1 
Undetermined 2 0 2 0 0 
Total HPV 
^ . , 3 3 4 3 4 typed samples 
Total screened 35 23 30 28 28 
The successful rate of this reaction was statistically no difTerent within 5 regions. 
y2= 0.65, p=0.957 by Fisher's exact test 
Chapter 3: Results W ] I 3 
M 2 1 
<- 150bp 
Figure 3.23 Electrophoresis of GP5+/6+ PCR products from LI region of HPV 
genome in cervical carcinoma tissues in agarose gel stained with 
ethidium bromide. Lane 1: HPV DNA positive samples; Lane 2: 
negative control of distilled water; M: size marker,巾x-174/HaeIII 
Markers. 
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3.7 Correlations of HPV prevalence, geographical variation, histology 
and age of the cervical cancer patients 
The overall HPV prevalence in cervical carcinoma in China was 83.9% and ranged 
from 79% - 88% by region. Thirteen types of viruses were detected through different 
methods. HPV 16 accounted for 79% of the total HPV positive specimens and did not 
have geographical variation (p = 0.00 by Fisher's exact test). The HPV 16 phylogenetic 
group, including HPV 16，31, 33, 35, 52 and 58, represented 87.3% of the viruses found. 
HPV 18 related group including HPV 18, 45 and 59, represented 8.6%. HPV 35, 53，67, 
70 were each found once in the specimens. The prevalence of HPV 52 and 58 in Hong 
Kong and Guangdong were statistically higher than other regions of China (p = 0.00092 
for HPV 52 and p = 0.011 for HPV 58 by Fisher's exact test). Three cases of double 
infection were detected in Shanghai, Sichuan and Guangdong. This showed that some 
rare HPV types varied geographically. (Table 3.7) 
The relationship between HPV type and histology was shown in Table 3.8. HPV 
16 or related virus accounted for 76.5% of the viral types found in squamous cell 
carcinoma (p = 0.00 by Fisher's exact test). HPV 18 and related viruses accounted for 
22.6% of the viral types in adenocarcinoma and 5.8% of the viral types in squamous 
cell carcinoma as well. HPV 18 was more prevalent in adenocarcinoma than squamous 
cell carcinoma, (p = 0.00 by Fisher's exact test).The prevalence of HPV 16 in 
squamous cell carcinoma was higher than that in adenocarcinoma, (p = 0.004 by 
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Fisher's exact test). No relationship was observed between HPV 52 or HPV 58 
infections and histology of the specimens (p 二 0.843 and p 二 0.541 by Fisher's exact 
test respectively). (Table 3.8) 
The correlation of the age of the Hong Kong patient and the HPV type were 
studied. The mean age of the specimens was 55.2. HPV 16 accounted for 60% (95/156) 
of Hong Kong patients. There was no significant difference in the incidence of HPV 16 
among the 3 age groups. However, HPV 52 and HPV 58 showed more prevalent in 
elder patients then younger patients (p = 0.008 for HPV 52 and p = 0.356 for HPV 58 
by Fisher's exact test). (Table 3.9) 
Different detection methods were applied to determine the HPV types in cervical 
carcinoma. The efficiency of each method varied in different regions and the results 
were summarized in Table 3.10. 
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Table 3.7 Prevalence of HPV in cervical cancer by different regions of China. 
^sRegions 
Shanghai Sichuan Beijing Guangdong Hong Kong Total 
HPV typeK^^^ 
11 0 0 0 1 2 3 
16 105 123 111 99 100 538 
18 3 11 4 7 24 49 
31 2 0 0 2 1 5 
33 1 1 0 0 10 12 
35 0 0 0 0 1 1 
45 0 0 1 2 0 3 
52 1 1 2 5 8 17 
53 0 0 0 0 1 1 
58 2 3 3 6 11 25 
59 1 2 0 2 2 7 
67 0 0 0 0 1 1 
70 0 0 0 0 1 1 
16,58 1 0 0 0 0 1 
18,31 0 0 0 1 0 1 
18,52 0 1 0 0 0 1 
Unknown 2 1 3 7 0 13 
Negative 32 20 26 19 33 130 
Total 150 163 150 151 195 809 
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Table 3.8 Prevalence of HPV type by histologic tumor characteristics 
Histologic type, No. Histologic differentiation degree, No. 
(% of total specimens) (% of total specimens) 
Type Squamous Adenocarcinoma Poor Moderate Well 
HPV 16 500(68.7) 28 (45.2) 96(60.9) 281 (67) 165(72.6) 
HPV 16 related* 17(2.4) 0(0) 3 (2.2) 11 (2.2) 4(1.9) 
HPV 18 33 (4.6) 13 (21) 11 (7) 25 (6) 13 (5.7) 
HPV 18 related 9(1.2) 1(1.6) 3 (2.2) 3(0.7) 2(1.2) 
HPV 52 16(2.2) 2(3.2) 2(1.7) 13(3.1) 0(0) 
HPV 58 25 (3.4) 1 (1.6) 7(4.8) 8(1.9) 10(4.4) 
Other 15(2.1) 0(0) 4 (2.5) 6(1.6) 4(1.9) 
HPV negative 114(15.4) 17(27.4) 28 (17.2) 70(17.1) 29(12.3) 
Total No. of 
729(100) 62(100) 157(100) 417(100) 227(100) 
specimen 
X2 =39.67, p=0.00 X2 =23.47, p=0.052 
* HPV 52 and HPV 58 were excluded 
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Table 3.9 Prevalence of HPV in cervical cancer by age in Hong Kong, 
group 
^ ^ <40 40-60 >60 Total 
HPV type 
11 0 1 0 1 
16 18 42 35 95 
18 7 15 2 24 
31 0 0 1 1 
33 2 3 5 10 
35 0 0 1 1 
52 1 2 5 8 
53 0 1 0 1 
58 0 2 9 11 
59 0 1 1 2 
67 0 0 1 1 
70 1 0 0 1 
Total 29 67 60 156 
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Table 3.10 Efficiency of different detection methods in different regions of China 
Regions, No. 
(% of total specimens) 
Method Shanghai Sichuan Beijing Guangdong Hong Kong 
MY-DNA 
. 22(18) 30(21) 20(16) 72 (57) 138(85) squencmg 、乂 
RFLP 36(31.5) 5 (3) 78 (64) 6 (5.7) 20(12.6) 
TS-primer 57 (48) 104(74) 21 (17) 44 (35) 0(0) 
GP-DNA 
Sequencing 3(2-5) 3(2) 3(2) 3 (2.3) 4(2.4) 
Total 119 143 121 126 162 
Clivipler 4; Discussion K 11K 
CHAPTER 4 
DISCUSSION 
4.1 Prevalence of HPV infection in cervical cancer in China 
The International Biological Study on Cervical Cancer conducted a research on the 
prevalence of HPV in cervical cancer in 22 countries except China (Bosch et al, 1995). 
The HPV prevalence ranged from 75% to 100% in different countries. It was found that 
HPV 16 was the predominant type in cervical carcinoma in most countries and some of 
the intermediate risk HPV types were only found in certain countries. It was found that 
HPV 45 was predominant in western Africa, whereas HPV 39 and HPV 59 were 
predominant in Central and South America. 
The studies of the relationship of HPV and cervical cancer in China were started in 
1987 (Zhang et al” 1987; Shu et al, 1987). After that several studies was conducted 
and continue until now. Among those studies, most of them were small-scaled and 
regional bounded. The detection methods used in the prevalence studies could influence 
the actual detection rate of HPV. In order to obtain a more accurate prevalence of HPV 
in cervical cancer, the detection methods were standardized. These include DNA 
sequencing technique, RFLP, HPV type specific primer PCRs and 2 sets of HPV 
consensus primer pairs. Nearly all the HPV types could be classified. 
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Sichuan 
The HPV detection rates in early 90s were lower than that research conducted in 
recent years. This was because the detection methods they choose. When using one or 
two HPV type specific primers and probes, only few HPV types could be detected. As 
the detection methods improved, using several HPV consensus primers and DNA 
sequencing could detect all the HPV types and this increased the detection rate of HPV 
in recent studies. The report of Peng in 1991 showed that only 35% (35/101) of cervical 
cancer cases were due to the infection of HPV. The positive specimens were the result 
of the infection of HPV 16. Both studies performed by Stephen AL et al (2000) and 
ours showed that the infection rate of HPV in Sichuan was 88% which were found to be 
higher than Peng's in 1991. The infection rate of HPV 16 and HPV 18 in Stephen's 
study was 61% and 9% respectively. HPV types 33, 45, 58 and 59 were also identified 
in the samples. Among our samples, the HPV infection rate was 88% (143/163) and the 
infection rate of HPV 16 was 86% (123/143). HPV 18 was the second most infected 
type that accounts for 8.4% of the positive cases. HPV 33, HPV 52, HPV 58 and HPV 
59 were also detected in the specimens. A novel finding in Sichuan was that the rate of 
HPV 58 and 52 infections came third and forth in the study. This showed that HPV 58 
and 52 were the high-risk HPV types in the development of cervical cancer in Sichuan. 
In our study, the relationship of histology types and HPV infection was also 
studied. Most of the HPV 16 infected samples were squamous cell carcinoma. In the 
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case of the infection of HPV 18, 33.3% were adenocarcinoma. This finding was 
coincidence with other research (Bosch et al, 1995). 
In order to study the risk factors of HPV in cervical cancer, Tang et al conducted a 
study on the prevalence of HPV in regions with high incidence and low incidence of 
cervical carcinoma respectively within Sichuan in 1992. The samples collected by PAP 
smear of 317 cases from high incidence area and 500 from low incidence area were 
used for the HPV 16 and HPV 33 type specific primers screening. The HPV infection 
rate in high incidence area was 18% whereas it was 3.4% in low incidence area. This 
revealed that the HPV infection rate in high incidence area of cervical carcinoma was 5 
times higher than that in the low incidence area. For the risk factors study, women were 
recruited from 2 different villages to complete a survey about personal hygiene 
situation, cigarette-smoking habit and sexual behavior with partners. It was concluded 
that in low incidence area, the marital status was stable and 95% of women had only 
one sexual partner. Besides, the harvest of the western part of Sichuan was much better 
than that in any other part of Sichuan, the vitamin absorption was more adequate than 
that in high incidence area. These suggested why the cervical carcinoma incidence was 
higher in high incidence area. 
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Shanghai 
In Shanghai, several studies on the relationship between HPV and cervical cancers 
had been reported. Hunag et al has conducted a survey of HPV prevalence in cervical 
cancer in Shanghai in 1997. In his study, specimens from 40 patients with uterine 
cervix carcinoma were collected from Shanghai Tumor Hospital and were examined for 
HPV DNA by PCR. The researchers used consensus primers (MY09/11) located in the 
LI region, as well as 10 different HPV type specific probes located at the same LI 
regions to detect the HPV DNA. During the HPV screening, positive results were 
shown in 35 samples, in which HPV 16 counted for 7.5% while HPV 18 counted for 
10% of the total. Moreover, HPV 52 and 58 demonstrated a high prevalence in this 
study, each of them counted for 15% of the HPV positive cases. 
Another research was conducted by Lin et al (1998) included 37 cases collected 
from 3 different hospitals in 2 different regions in eastern China: Shanghai and Jiangxi. 
Eighteen samples of frozen tissue were obtained from the Shanghai Tumor Hospital; 
while in the Shanghai Hospital of Obstetrics and Gynecology, 19 samples of 
formalin-fixed, paraffin-embedded tissues were found. Besides, 40 cases of frozen 
cervical cancer tissue were obtained from the Jiangxi Provincial Maternity Institute. 72 
cases were diagnosed as squamous cell carcinoma of the cervix and 5 cases as cervical 
adenocarcinoma. In this study, two sets of HPV consensus primer pairs including 
MY09/11 and GP5+/6+ were used for HPV DNA screening. A prevalence rate of HPV 
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infection in frozen tissues and paraffin-embedded tissues were 83.3% and 89.5% 
respectively. In Jiangxi, the infection rate of HPV in cervical carcinoma was 100%. 
Among the 3 hospitals, different HPV types had different prevalence. The prevalence of 
HPV 16 detected in cervical carcinoma was different in Shanghai and Jiangxi Province. 
At 2 hospitals in Shanghai, the HPV 16 infection rates were 27.8% and 15.8% 
respectively, whereas the rate in Jiangxi was 70.9%. However, HPV 52 was absent in 
the paraffin-embedded tissue when it was detected in the fresh tissue specimens from 
Shanghai and Jiangxi. In the frozen tissue from Shanghai, the percentage of infection 
was 16.7%, but it was only 2.5% in Jiangxi. When comparing with the prevalence of 
HPV 58, there was no significant difference in the infection rate of the two places, they 
are 15.8% to 22.2%. 
In our study, 150 paraffin-embedded cervical carcinoma tissues were collected for 
HPV DNA screening. HPV DNA was detected in 80% of the samples, while HPV 16 
accounted for 90% of them. Moreover, HPV 18, HPV 31, HPV 33, HPV 52, HPV 58 
and HPV 59 were also detected. My finding about HPV 16 infection rate was similar to 
the pervious one and was dominate in the cervical carcinoma (Lin et al, 1998). HPV 18 
counted for 2.5% of total. In Lin's study, HPV 18 was not detected in any specimens 
from Shanghai. This demonstrated that the infection rate of HPV 18 in Shanghai was 
relatively lower than the others. The International Biological Study on Cervical Cancer 
also gave a report on the prevalence of HPV in cervical cancer in a worldwide 
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perspective by stating that 13.7% of HPV infected cervical carcinoma were infected by 
HPV 18. 
Besides HPV 16, HPV 58 was the second most commonly found in our study, 
counting for 2.5% of the HPV infected cervical carcinoma. The positive rate of this 
study was lower than the previous one done by Huang et al and Lin et a\. The 
difference between the result of my study and those of the pervious ones might be 
attributed to the sampling from different regions. Lin et al suggested that the risk 
factors of different regions might cause the difference in the prevalence of HPV types. 
HPV 52 was another type of HPV, which was uncommon in other countries. From 
the pervious studies, the infection rate of HPV 52 was higher than other HPV types 
(Lin et al, 1998). In my study, only 1 case of HPV 52 was detected. However, this 
observation might indicate a variation of HPV epidemiology among Shanghai living in 
different geographic areas. 
Beijing 
In 1990, Zhang et al conducted a research on the relationship between HPV and 
cervical cancer. Thirty-eight cervical carcinomas and 1 cervical condyloma were 
examined for the presence of HPV type 16 DNA by using 3H-dCTP-labelled HPV-16 
probe and the results showed that the HPV-16 DNA positive rate was 74.4% (29/39). 
In 1991, Zhang et al. did another research on HPV and cervical carcinoma. A 
large-scale survey was conducted to investigate the association between cervical 
Chapter 4: Discussion I'. I ：> 1 
carcinoma and human papillomavirus infection in a high-risk area, Xiangyuan Country, 
Shanxi Province. There were 6710 women examined using Dot blot hybridization with 
HPV 6B/11, 16 and 18 DNA probes. Fourteen cases were diagnosed as invasive 
cervical carcinoma and 40% of them were infected by HPV 16. 
Zhang et al. also conducted the third research on HPV and cervical carcinoma. 
This time, he used HPV 16 E6 type specific primer for screening and the result was that 
30 specimens were shown to be infected by HPV 16. 
In our 150 specimens, all were classified as squamous cell carcinomas in which 
HPV 16 was also dominant (111/124, 90%). This finding was similar with the pervious 
studies. 
Besides Zhang, Zhao et al. did a research by using LI consensus primer for the 
detection of HPV DNA in cervical cancer tissues in Shanxi Province. In his study, the 
PCR amplification was carried out. After that, the PCR products for HPV typing were 
used for carrying out restriction enzyme digestion. By using this method, HPV 16 and 
HPV 18 could be classified. In fact, 20 cervical adenocarcinoma and 20 squamous cell 
carcinoma specimens were collected for this study and the result was that the HPV 
infection rate of total 40 samples was 85%. For adenocarcinoma, HPV 18 were detected 
in 9 specimens (45%) and only 5 specimens were detected with the infection of HPV 16 
(15%). For squamous cell carcinoma, 80% of the samples were detected with the 
infection of HPV 16 while 5% were detected with the infection of HPV 18. 
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Among all these studies, it was obvious that HPV 16 was found to be dominated in 
cervical carcinoma and in squamous cell carcinoma whereas HPV type 18 was found to 
be more prevanlent in adenocarcinoma tissues. However, since either HPV 16 or HPV 
18 type specific probes or primers was the only tools used for detecting HPV 16 or 
HPV 18, except the one by Zhao et al., it could not reflect the real situation of HPV 
infection in cervical carcinoma. 
In order to determine the real situation of HPV in cervical cancer, a large scaled 
and standardlized methods were used in this study. One hundred and fifty 
paraffin-embedded cervical carcinoma tissues were collected in Beijing and screened 
by using HPV consensus primer pairs MY09/11 and GP5+/6+. DNA sequencing, 
restriction fragment length polymorphism and HPV type specific primers were used to 
determine the HPV types. The infection rate of HPV in cervical carcinoma was 82.6% 
and HPV 16 counted for 90% of the HPV infected samples. There were many other 
types of HPV detected, HPV 18, HPV 45, HPV 52 and HPV 58. HPV 18 was all the 
second most common infection in this study. Since in these 150 specimens, all were 
classified as squamous cell carcinomas in which HPV 16 was dominant, this explained 
why the infection rate of HPV 18 was not as higher as other studies. 
HPV 58 and HPV 52 were also shown to have a high prevalence than other types 
were compared with Shanghai (eastern part of China) and Sichuan (western part of 
China), the prevalence of HPV 52 and HPV 58 was higher than that of other 
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intermediate risk HPV types in other countries. 
Guangdong Province 
Guangdong Province is located in the southwestern part of China. In our study, 
Guangdong Province was chosen to compare the difference of HPV prevalence in 
cervical carcinomas with that of the other parts of China. The cervical carcinomas 
tissues collected from Beijing, Sichuan and Shanghai representing different situation in 
different parts of China. 
Besides, in this study, the specimens were collected at Zhongshan city in 
Guangdong Province and no study about cervical cancer and HPV conducted at this city. 
In our research, there were 151 paraffin-embedded cervical carcinoma tissues collected 
during the period 1998-2000 and among them, one hundred and thirty-two specimens 
(87.4%) contained HPV DNA, in which 75% were found to be infected by HPV 16，8 
specimens were infected by HPV 18, 6 were infected by HPV 58 and 5 specimens were 
infected with HPV 52. Meanwhile, HPV 31, HPV 45 and HPV 59 were also detected. 
However, 7 specimens were detected with the infection of HPV DNA but they could 
not be typed. 
Hong Kong 
Since 1990's, the scientists of the University of Hong Kong and the Chinese 
University of Hong Kong has conducted studies on the HPV and cervical carcinoma. 
Yiu et al had conducted a research, in which 15 cervical carcinoma tissues classified as 
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squamous cell carcinoma undergoing Southern blot hybridization were used to test the 
presence of HPV DNA. The result was that 13 specimens (86.7%) were showed to have 
HPV DNA in which 9 of them were infected with HPV 16，2 of them were infected with 
HPV 18 and 2 were infected with HPV 16 related types. 
In 1994, Ngan et al used HPV 16 and HPV 18 E6 type specific primers to screen 
64 cervical carcinoma tissues. The result was that 90% (58/64) of the samples showed 
positive in the HPV DNA screening and 67.2% had a HPV 16 infection. 
In 1996，Chan et al. collected 488 Hong Kong Chinese women's cervical scrapes 
obtained from the colposcopy, general, and antenatal clinics and the result was that nine 
out of 217 patients seen in colposcopy clinic were diagnosed as squamous cell 
carcinoma and adenocarcinoma. 88% of cervical carcinoma specimens were detected 
with HPV DNA infection. 
From these studies, HPV was predominant in cervical carcinoma. In our study, the 
HPV DNA was found in 162 cases (83%) and HPV 16 was still the predominant type 
of HPV high risk type in cervical cancer. This result was similar with the pervious 
studies. (Yiu et al, 1991; Ngan et al, 1994; Chan et al, 1996) 
In 1999, Chan et al. conducted a research on 322 Hong Kong women with 
abnormal Papanicolaou smears using PCR and RFLP analysis. Only 18 specimens were 
invasive cervical carcinoma. Among the cervical carcinoma, 14 were infected with 
HPV. There were 8 specimens infected by HPV 16 (44.4%), 6 by HPV 58 (33.3%), and 
Chapter 4: Discussion I'. I ：> 1 
HPV 18 and HPV 31 were detected only once respectively. In his study, the high 
prevalence of HPVS 8 in cervical carcinoma and also in other grades of cervical lesions 
were detected. 
Another study conducted by Liaw's also shown high prevalence of HPV 52 and 
HPV 58. They were detected among 25% of HPV positive subjects compared with a 
large international study conducted by IBSCC in 1995 that only 5% of HPV positive 
subjects were used for the detection of HPV 52 and HPV 58. 
The incident of HPV 58 in this study was high (6.79%, 11/195). This observation 
was similar to others (Liaw et al” 1995; Huang et al 1997; Chan et al, 1999) that HPV 
58 showed high prevalence in cervical cancer among Chinese population. 
These observation indicated the presence of the worldwide uncommon genotype; 
and among them, HPV 58 plays an important role in the development of cervical cancer 
among Chinese. 
In this study, 195 fresh cervical carcinoma tissues from Hong Kong were collected 
at the Prince of Wales Hospital, HKSAR, China from 1991 to 1998. Although the tissue 
preparation of Hong Kong was different from other sets of specimens that were 
paraffin-embedded, the screening methods were the same. The HPV DNA was found in 
162 cases (83%). These included HPV 16 in 100 (61%) cases, HPV 18 in 24 (14.8%) 
cases, HPV 31 in 1，HPV 33 in 10 (6.17%), HPV 35 in 1, HPV 52 in 8 (4.93%) cases, 
HPV 58 in 11 (6.79%) cases, HPV 59 and HPV 11 in 2 respectively and HPV 67 and 
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HPV 70 in 1 respectively. The variety of HPV types in Hong Kong was great. Twelve 
different HPV types were detected. HPV 16 was still the predominant type of HPV high 
risk type in cervical cancer. Eleven (45%) cases of HPV 18 infected were classified as 
adenocarcinoma. 
Regional comparison of HPV prevalence 
In the studies of Hong Kong and Guangdong, the high prevalence of HPV 58 and 
HPV 52 were detected. In Beijing, Sichuan and Shanghai, the prevalence of HPV 52 
and HPV 58 were comparatively lower than that of Hong Kong and Guangdong. 
However, these uncommon HPV types were shown more prevalent in China than other 
countries in the world. Comparing the prevalence of different HPV types in different 
countries, Japanese studies showed a lower prevalence of HPV 16 and HPV 18, but 
higher prevalence of HPV 52 and HPV 58. (Yajima H et al, 1988, Matsukura T et al, 
1990) In the United States, studies showed a higher prevalence of HPV 16 and HPV 
18 but lower prevalence of HPV 52 (Shimoda et al, 1988). The prevalence of different 
HPV types in different geographical locations might indicate different etiologies of 
cervical cancer. In this study, the prevalence of HPV 52 and HPV 58 in the southeastern 
part were higher than that of other parts of China. Although the overall prevalence of 
HPV among Chinese women was similar to that described in Western countries, the 
distinct high proportion of HPV 52 and HPV 58 infection drawn an attention. During 
designing the HPV detection methods and clinical treatment methods in cervical 
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carcinomas of Chinese, 2 HPV 16 related types, HPV 52 and HPV 58 should be 
carefully considered. 
The overall prevalence of HPV in cervical cancer of 5 regions of China was 
83.93% and there was no significant difference in geographical distribution. According 
to Walboomer's study, the HPV prevalence in cervical cancer was 99.7%. The reason 
for this high prevalence may be the improper sampling; disruption of HPV by 
integration events; the existence of still unidentified HPVs; sensitivity of the method; 
and the mechanism of transformation. The advantages and disadvantages of different 
detection methods will be discussed in next section. 
In this study, the prevalence of HPV 16 was still predominated in cervical cancer. 
This results were consistent with many reports on HPV in cervical cancer 
internationally (zur Hansen, 2000; Walboomers et al, 1999; Bosch et al. , 1995). The 
overall HPV prevalence did not vary between histologic tumor types, suggesting an 
etiologic consistency among squamous cells tumors, adenocarcinomas and 
adenosquamous carcinomas. 
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4.2 DNA extraction and HPV detection methods 
Due to the DNA extraction methods and HPV detection methods could influence 
the detection rates of HPV, the discussion on these subjects will be make in this section. 
The paraffin embedded tissues were collected from 4 different regions in China. 
Paraffin wax embedded tissues are valuable source of DNA for analysis. The use of 
paraffin-embedded for tissue storage is easy and it has been used for years. In fact, 
there were many factors affecting the DNA quality of the paraffin embedded tissues, 
they were the use of fixative, the fixation time, the storage time and condition and the 
extraction method. 
In modem science, PCR is a routine method to detect the presence and amplify the 
DNA. The effect of fixative in paraffin embedded tissues should be studied in order to 
avoid the negative effect in PCR. Buffered neutral formalin (BNF) was used in 
preparing the paraffin-embedded tissue. In two studies, the sizes of DNA fragments 
from the tissues were fixed in 10% buffered neutral formalin ranged from 100 to 
l，500bp (Goelz et al, 1985) to from 4,000 to 9,000bp (Amheim et al, 1990). The 
extracted DNA from paraffin embedded tissues was the template for the PCR, therefore, 
the researcher should know the preparation condition since it would be an advantage in 
the analysis of the result. Greer et al. conducted a study on the effect of fixative and the 
fixation time of paraffin-embedded tissues in PCR amplification. In his study, 11 
fixatives and 3 fixation time slots were tested. 10% buffered neutral formalin were 
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found to be the best for the subsequent analysis by PCR. Extraction method of 
paraffin-embedded tissues was another factor affecting the efficiency of PCR. Chan et 
al (2001). conducted a research by using different DNA extraction methods including 
tradition phenol/chloroform, microwave based (Baneijee et al, 1995) and commercial 
available spin column based DNA extraction kit. The traditional method of purifying 
DNA from archival tissues using xylene dewaxing followed by phenol/chloroform 
purification is laborious and requires multiple steps that are prone to cross 
contamination. Although the performance of phenol/cholorform in extracting 
paraffin-embedded DNA is not as good as other methods, it is cheap and readily 
available in most laboratories. In Chan's research, primers targeted at a 509bp fragment 
and 355bp fragment in /5 globin gene were chosen for DNA testing. The positive rates 
of phenol/chloroform, microwave based, and Qiagen spin column methods were, 50%, 
60% and 50% for the 509 bp 冷 globin PCR respectively; for 355bp/3 globin PCR, the 
figures were 90%, 95% and 95% respectively. Extracted DNA were also subjected to 
two sets of HPV consensus PCR, MY09/11 and GP5+/6+. The positive rates of 
phenol/chloroform, microwave based, and Qiagen spin column methods were 25%, 
50% and 65% for MY09/11 respectively; for GP5+/6+ PCR, the figures were 60%, 
60% and 75% respectively (Chan et al, 2001). 
In our study, phenol/chloroform was used to extract the DNA from 
paraffin-embedded tissues and the extracted DNA were subjected to a primer pair 
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targeting at a 303bp fragment of the human (3 actin gene (GeneBank Accession No. 
X00351) for the assessment of integrity of DNA extraction. There were 358 
paraffin-embedded tissues subjected to /5 actin PCR and all gave a positive results. 
According to the study of Chan et al, DNA extraction by using phenol/chloroform 
method might be underestimated for detecting the HPV DNA. In our study, the 
phenol/chloroform extracted DNA were first screened with MY09/11 PCR. This 
screening ensured the picking up of HPV in phenol/chloroform extracted DNA. The 
MY09/11 negative samples were then screened using actin primer and TS primer. 
These methods eliminated the underestimation of the HPV samples. 
In detecting the HPV DNA in the cervical carcinomas tissues, HPV DNA could be 
integrated into the host DNA or in episomal circular form. This explained that even the 
/3 actin gene extracted, the HPV DNA could still not be extracted and vice versa. In 
fact, even the copy numbers of冷 actin gene were lower than HPV DNA, the actin 
PCR negative result samples could also contain the HPV DNA. Therefore the copy 
numbers of HPV DNA in the cervical carcinoma tissues might affect the efficiency of 
extraction of DNA. In a way that the higher the copy numbers of HPV DNA was, the 
greater the chance of HPV DNA extracted. 
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Polymerase chain reaction 
Polymerase chain reaction is a very useful and common molecular method to 
amplify a fragment of DNA sequence. There were many HPV consensus primer pairs 
developed to detect different HPV types by using single PCR. There were 2 most 
commonly used PCR primer sets, MY09/11 and GP5+/6+ and they were used for the 
detection of HPV DNA in clinical cervical carcinoma tissues. The MY09/11 primer set 
was synthesized with several degenerate nucleotides in each primer and was thus a 
mixture of 25 primers. The GP5+/6+ primer set consisted of a fixed nucleotides 
sequence for each primer and thus it detected a wide range of HPV types by using 
lowered annealing temperature during PCR. Both the MY and GP+ primer sets targeted 
at the highly conserved LI ORF of the HPV genome. The GP+ primer set was 
complementary to the part of the LI region located inside the sequence recognized by 
the MY primer set. Therefore, they can be used either as a single primer or in the nested 
PCR after the amplification with the MY primer set (Evander et al, 1992) MY09/11 
primer set yielded about 450bp of DNA fragment in PCR and GP5+/6+ primer yielded 
150bp DNA fragment. 
In fact, MY09/11 primer set first was used first to screen HPV DNA in paraffin 
embedded and fresh prepared cervical carcinoma tissues and the result was that from 
37.7% to 78.8% for paraffin embedded and 94.4% for fresh prepared tissue. The overall 
positive rate using MY09/11 was 60%. The specimens from Sichuan and Beijing 
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showed relatively low positive rate in using MY primer set. The reason for that 
difference may be due to the storage time of the paraffin-embedded tissues. The 
paraffin-embedded tissues from these 2 regions were stored for about 5 years and the 
samples from Shanghai and Guangdong were stored less than 2 years. Although Shibata 
et al succeeded in amplifying a 40-year-old paraffin-embedded tissues but Goelz et al 
reported that the longer the storage time was the shorter the DNA fragments produced 
when comparing that of a fresh prepared paraffin-embedded tissues. The use of 
formalin in the preparation of the paraffin-embedded tissues may cause the disruption 
of LI regions of HPV DNA to produce shorter fragments in DNA extraction. Several 
authors have reported difficulties in reproducing PCR results with formaldehyde-fixed 
tissues (Ben-Ezra et al, 1991; Goodrow et al, 1992; Thompson et al, 1991). Karlsen 
et al had described the antagonistic effect of formaldehyde fixation resulting from DNA 
modification, which led to the inhibition of PCR amplification of longer than 200bp 
amplimers. Since MY09/11 amplified a long LI region (450bp) in HPV, the chance of 
DNA disruption within this region was high. In this case, the PCR showed a negative 
result. This would produce an underestimated result of HPV infection. As a result, the 
quality of extracted DNA from Sichuan and Beijing might not suitable for the MY PCR 
due to the longer storage time and tissue preparation. 
Different HPV types have different disruption patterns. In Walboomers (1999) 
study, PCR assay targeting at the LI fragments only had 50 percent positive rate of the 
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E7 PCR positive cases and this suggested the presence of interruptions or deletions in 
the HPV DNA at the level of the LI ORE HPV 18 was more often disrupted in the LI 
region than other HPV types, this would imply that PCR assays targeting at other ORFs 
were required to determine the true prevalence in adenocarcinomas because it usually 
infected by HPV 18 (Walboomers et al, 1999). 
In order to solve the motioned difficulties, different HPV type specific primer 
PCRs that could amplify other ORFs, E6 and E7 were used. Before the discussion of 
the use of HPV type specific primer PCRs, 2 HPV typing methods, Restriction 
Fragment Length Polymorphism and DNA sequencing will be introduced. 
Restriction fragment length polymorphism 
The restriction enzymes were used to digest the DNA to give distinct fragments in 
Restriction Fragment Length Polymorphism. Each type of HPV DNA genome had their 
unique DNA sequence. When digesting with different kinds of restriction enzymes, it 
would possess a unique DNA fragments. By interpreting the fragments, HPV types can 
be identified. The templates for RFLP were the PCR products of MY09/11 primer pair. 
Since MY09/11 primer pairs were commonly used in the routine HPV detection, by 
using the products of the PCR, the typing procedure could be simple and easy to 
prepare. Since each PCR produced 50 fi 1 amplified DNA, and each RFLP just used 5 ji 
1 of the amplified DNA, so even just 1 reaction tube could produce enough template for 
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typing. This could be valuable if the extracted DNA was in a limited amount. Apart 
from material saving, the reaction time was also short. The required reaction time for 
RFLP was about 1 hour, so the HPV type could be confirmed within 4 hours from the 
MY PCR to RFLP. These advantages make RFLP method become a powerful, quick, 
cheap and reliable HPV typing tool. 
In order to avoid potential errors in the visual scanning of the DNA bands, a high 
concentration of agarose gel was used in the study since high resolution of DNA 
fragments could be achieved by high concentration of agarose gel. Also the 
computerized image taking system could help to produce higher resolution of the gel 
image. In our study, Gel Doc 1000 system by BioRad laboratories was used to produce 
a high-resolution gel image. 
All the above advantages were the reasons to use RFLP for HPV typing in this 
study. In our study, Rsa I and Dde I were chosen to perform RFLP. These 2 restriction 
enzymes produced distinct DNA fragments for high-risk types of HPV, so it was easily 
to be distinguished from type to type. All the MY09/11 positive specimens and 
unsuccessful in DNA sequencing were undergone RELP analysis. For example, in 
Beijing, 63% of the HPV specimens could be typed by using RFLP analysis. In 
Shanghai and Hong Kong, about 30% and 12% of HPV types were typed by RFLP 
respectively. In Sichuan, only 3.4% of specimens were successfully typed by using 
RFLP for HPV typing and it was because the qualities of PCR products amplified by 
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MY09/11 were not suitable for both DNA sequencing and RFLP. Using HPV type 
specific primers could type most of the specimens from Sichuan. 
DNA sequencing 
DNA sequencing is a powerful and accurate tool in determining the nucleotides 
sequence of HPV DNA. The advantages of DNA sequencing are that all HPV types can 
be confirmed by comparing the Genebank sequence data and it is easy to confirm a new 
type or variants of HPV. 
The quality of PCR products played a very important role in preparing the 
template for sequencing. In this study, the templates of the sequencing reaction were the 
PCR products of MY and GP+ primer sets. They were purified by Microspin coloumn 
provided by Pharamica, USA. Another method to purify the template was DNA 
extraction from agarose gel. After the agarose gel electrophoresis of the PCR products, 
the target band was excised under UV light and extracted using QiAqucik gel extraction 
kit. After the DNA extracted, they stored in 50 //1 TE buffer or autoclaved water. As 
the DNA should be concentrated for DNA sequencing, the 50 ji 1 DNA were dried 
under vacuum for 15 minutes to 6//I before performing DNA sequencing. 
It should be reminded that the time of exposure of UV light to the agarose gel 
should be minimized since UV could cause cross-link of DNA and would degrade it. 
Also a study indicated that when such direct sequencing is used, it would be necessary 
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to have reamplification and cloning to resolve some sequence results that are difficult to 
interpret. 
The drawback of the direct sequencing methods was the low quality of the 
sequencing reaction on the template of PCR fragments, characterized by the frequent 
"strong stops". This resulted in the fact that the bands in all four lanes (A, G, C, T) 
could not be distinguished secondary structure related impediments instead of the 
desired termination only at the places of dideoxymucleotide incorporation. Indeed, the 
existence of the latter result was due to an incorrect DNA chain termination. Cycle 
sequencing is a method to reduce the secondaty strcutre-related sequencing ambiguities. 
HPV Type Specific PCR 
The HPV type specific PCR was another method for HPV typing. All the HPV type 
specific primers targeted at the HPV E6 or E7 ORFs regions. To use the E6 and E7 
ORFs for typing specific regions could avoid the disadvantages of using LI primers 
that discussed in the pervious sections. HPV E6 and E7 were the oncogenes causing 
cervical carcinomas and they had to be present in the tissue. The primers targeted at 
these regions could easily amplify the target HPV DNA if the specimens were infected 
by HPV. 
The detection rate of using MY09/11 primer set screening in the whole study was 
60%. After HPV type specific PCRs, the detection rate increased to 83.3%. This result 
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showing that using MY09/11 LI consensus primer was not enough to detect the HPV 
DNA in the samples, there was a need to combine both consensus structural LI gene 
derived primers and type-specific viral oncogene E6 and E7 derived primers in order to 
detect HPV DNA in cervical cancer specimens more accurately. 
After the screening of MY09/11 and type specific primers, another set LI 
consensus primer pair, GP5+/6+ was used to screen the HPV DNA. The reason for 
performing this screening was to detect the uncommon HPV types that could not be 
detected by pervious methods. The specimens showed positive results of GP5+/6+ all 
undergone DNA sequencing. HPV 35, 45, 59 and 67 could also be detected from these 
specimens. 
In this study, using RFLP and DNA sequencing could detect most of the HPV 
types even the novel HPV types. However, the limitation of these 2 methods was that 
they all needed MY09/11 PCR products as the templates. If the samples were negative 
with MY09/11 PCR, HPV could not be typed. As a result, using HPV type specific 
primer PCRs targeted the E6 or E7 regions to screen the specimens could help to detect 
the HPV DNA when HPV LI regions was disrupted. So, as we can see, the whole 
methodology established in this study could help detecting most of the HPV types in 
the paraffin-embedded and fresh cervical carcinoma specimens including those rare 
ones. 
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4.3 Intratype variation of HPV 
Several researchers had done the studies of intratype variation in HPV. Most of 
these studies targeted of the genome with high intratype variation, such as the URR, 
the E6 and the L2 ORFs. The reason to choose the LI region for detection of intratype 
variation was that the variation in this region allowed the distinction and assessment of 
known and novel HPV types and for HPV diagnostic purposed as well. 
Yamada suggested that nucleotides changes in the LI region were linked to 
different regions of HPV genome (Yamada et al, 1995). Linkage between intratype 
variant patterns in different parts of the genome should not be taken as an evidence for 
a causal connection, since mutation in different parts of the genome might be 
independent events. 
The definition of new HPV type is more than 10% difference in its nucleotide 
sequence compared with other known HPV types in the E6, E7 and LI open reading 
frames combined (de Villiers et al, 1989; van Ranst et al, 1993). Isolates within the 
same type differing by 0 to 2% in their nucleotide sequences compared with the 
reference sequence are regarded to as variants, and those differing by 2 to 10% are 
regarded to as subtypes. Stewart et al. had done the study on the LI region by using 
MY09/11 primer set. In his study, the PCR products were cloned and about 410 
nucleotides were sequenced. Within a single HPV type, nucleotide diversity varied 
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between 0.2% and 2.9% 
In some previous studies, the intratype variation for genital HPV types varied from 
1% - 5% within ORF; in URR, the variation was approximately 5%. 
PCR amplification using Taq polymrase could produce amplification error of the 
sequences. The transitions of T — C or A — G and G — A or C — T were common 
errors using Taq polymerase. 
In my study, using ALFexpress from Amersham Pharamacia Biotech, and ABI 
377 DNA Sequencer from Applied Biosystem sequenced 451 specimens of MY09/11 
PCR products. The sequencing reaction resulted in a range from 150 nucleotides to 404 
nucleotides and the diversity was varied between 0 to 2%. This showed that there was 
no intratype variation in the specimens. 
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CHAPTER 5 
CONCLUSION AND FUTURE PERSPECTIVE 
Extensive, accurate and systemic methods were used to determine the 
prevalence of HPV in cervical cancer in China. PCR with HPV consensus primer 
pairs MY09/11 and GP5+/6+ were used in the screening for HPV DNA in the 
samples. DNA sequencing，restriction fragment length polymorphism and HPV type 
specific PCR were used for HPV typing. 
The results showed that the mean prevalence of HPV infection in cervical 
cancer in five regions of China was 83.93% (range: 80% - 88%). There was no 
statistically significant geographic difference in HPV infection in cervical cancer. 
The findings from this study indicated that HPV 16 was the predominant type 
of HPV infection in cervical carcinoma in nation-wide China. The result was 
consistent with other reports (zur Hansen, 2000; Walboomers et al, 1999; Bosch et 
al, 1995). The infection rates of HPV 18, HPV 31, HPV 52 and HPV 58 were 6%, 
1.40/0, 2.1%, and 3.1% of the total specimens respectively. The infection rates of 
HPV 52 and 58 in the southeast part were higher than that in other regions of China. 
Specific HPV types might pose different relative risks for cervical cancer in 
different geographic regions. 
The histological distribution of the tumors was as follows: squamous cell 
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carcinoma - 729 (90%); adenocarcinoma - 62 (7.6%); and other types - 18 (2.4%). 
The overall HPV prevalence did not vary among different histologic tumor 
types, and this suggested an etiologic consistency among squamous cells tumors, 
adenocarcinomas and adenosquamous carcinomas. 
The PCR products of MY09/11 and GP5+/6+ were sequenced and compared 
with the known HPV sequences in the genebank. The variance of HPV type 
sequences in this study was 1 - 2%, indicated that there was no intratype variation of 
HPV in these specimens. 
Future development in HPV DNA detection 
The detection methods for HPV DNA have been updated recently. A new set of 
HPV general consensus primer, SPIO, was developed. It is used to amplify a 
fragment of 65bp from the LI region, (van Doom et al, 2000) LI region is still the 
target region in the development of new consensus primers. The trend of 
development of new sets of primers are aiming at producing short PCR products that 
the MY primer set is 450bp whereas GP5+/6+ is shortened to 150bp and now the 
new SPIO is just 65bp. In fact, the shorter size of PCR products gives an advantage 
in detecting clinical samples in. In the sense that most of the false negative results 
were due to the misamplification of the HPV DNA as discussed before. So, The 
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shorter the target PCR product can enhance the efficiency even the LI region is easy 
to be disrupted, the chance of breakage at the 65bp region is low. 
Apart from the new consensus primer, which provides an effective, rapid and 
simple method in detecting the HPV DNA, quantitative PCR is another method to 
detect the HPV DNA in the cervical carcinomas. By using the fluorescent 5’ 
exonuclease assay the number of oncogenic HPV can be detected and quantitated. In 
fact, quantitation over a range of 10 to 10,000,000 initial HPV copies was possible 
by using real-time detection of the accumulation of fluorescence with cycle numbers. 
By using this technique, not only the HPV DNA can be detected, the copy numbers 
of HPV can also be determined. 
Future perspective in HPV and cervical cancer research 
The molecular pathogenesis of cancer caused by high-risk HPV infections is 
not fully understood now. In the HPV 2000 International Papillmavirus Conference, 
some studies on the biology of papillomavirus had been done. Some novel function 
of viral protein, transcription control mechanisms, and intratype variants had been 
published. The availability of pseduovirions and the use of raft cultures continued to 
be useful for unraveling the life cycle of PVs, which will allow new approaches for 
the therapeutic interventions. 
The development of PVs vaccine is an important issue in clinical field. Studies 
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of the immune response of HPV provide valuable information in developing the 
vaccine. The experiments performed to measure the immune response to the PVs 
antigens in human are useful in the sense that they help finding out the natural 
history of PV infections. The role of specific PVs infection in diseases is not yet 
clarified. (Bosch et al” 2001) . VLP based vaccines are still the most promising 
agents in preventing PV infection including cervical cancer. In the near future, the 
study of the immunotherapy for PV infection will help to the development of 
powerful and antigen specific vaccine to control the PV associated cancer. 
Another aspect related to HPV is the cervical cancer screening program. For 
years, cervical cancer screening program is a major prevention program for women 
to prevent cervical cancer by simple and fast methods - PAP smear. As there is an 
improvement in the HPV detection methods, more accurate detection of HPV types 
in the specimens can have a prognostic significance to the cervical cancer. So in the 
course of development of detection methods, HPV type specific detection come to 
the first priority. Since knowing the prevalence of HPV types in cervical cancer in 
China can help the development of more effective treatment. 
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